background	NN	ROOT
:	:	punct

patent	NN	compound
owner	NN	nsubj
bring	VBD	ROOT
action	NN	dobj
against	IN	prep
manufacturer	NN	pobj
of	IN	prep
generic	JJ	amod
pharmaceutical	JJ	compound
product	NNS	pobj
,	,	punct
allege	VBG	advcl
infringement	NN	dobj
of	IN	prep
patent	NNS	pobj
recite	VBG	acl
improve	VBN	amod
formulation	NN	dobj
of	IN	prep
oxycodone	NN	pobj
and	CC	cc
patent	NNS	conj
claim	VBG	acl
technology	NN	nsubj
make	VBG	ccomp
tablet	NNS	nsubj
resistant	JJ	ccomp
to	TO	aux
abuse	VB	xcomp
.	.	punct

follow	VBG	prep
bench	JJ	compound
trial	NN	pobj
,	,	punct
the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	nsubj
for	IN	prep
the	DT	det
Southern	NNP	compound
District	NNP	pobj
of	IN	prep
New	NNP	compound
York	NNP	pobj
,	,	punct
Sidney	NNP	compound
H.	NNP	compound
Stein	NNP	conj
,	,	punct
J.	NNP	appos
,	,	punct
994	CD	nummod
F.Supp.2d	NNP	appos
367	CD	nummod
,	,	punct
find	VBN	ROOT
patent	NNS	nsubj
infringe	VBN	ccomp
and	CC	cc
invalid	JJ	conj
as	IN	mark
anticipate	VBN	advcl
by	IN	prep
or	CC	cc
obvious	JJ	conj
over	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct

patent	NN	compound
owner	NN	nsubj
appeal	VBD	ROOT
.	.	punct

 	_SP	

holding	NNS	ROOT
:	:	punct

the	DT	det
Court	NNP	nsubj
of	IN	prep
Appeals	NNPS	pobj
,	,	punct
Prost	NNP	appos
,	,	punct
Chief	NNP	compound
Judge	NNP	appos
,	,	punct
hold	VBD	ROOT
that	IN	dobj
:	:	punct

 	_SP	

claim	NNS	ROOT
recite	VBG	acl
oxycodone	NN	nmod
active	JJ	amod
pharmaceutical	NN	amod
ingredient	NN	nmod
(	-LRB-	punct
API	NNP	nmod
)	-RRB-	punct
product	NN	dobj
with	IN	prep
low	JJ	amod
alpha	NN	pobj
,	,	punct
beta	NN	nsubj
unsaturate	VBN	ccomp
ketone	NN	dobj
(	-LRB-	punct
ABUK	NNP	nmod
)	-RRB-	punct
level	NNS	nsubj
be	VBD	ccomp
invalid	JJ	acomp
for	IN	prep
obviousness	JJ	pobj
,	,	punct
and	CC	cc

 	_SP	

patent	NN	compound
cover	VBG	csubjpass
abuse	NN	npadvmod
-	HYPH	punct
resistant	JJ	amod
formulation	NNS	dobj
be	VBD	auxpass
anticipate	VBN	ROOT
by	IN	agent
prior	JJ	amod
art	NN	compound
reference	NN	pobj
.	.	punct

 	_SP	

This	DT	det
appeal	NN	nsubj
arise	VBZ	ROOT
from	IN	prep
consolidated	JJ	amod
Hatch	NNP	compound
-	HYPH	punct
Waxman	NNP	compound
proceeding	NNS	pobj
involve	VBG	acl
the	DT	det
reformulate	VBN	amod
version	NN	dobj
of	IN	prep
the	DT	det
pain	NN	compound
reliever	NN	pobj
OxyContin	NNP	compound
(r)	SYM	appos
.	.	punct

the	DT	det
Appellants	NNPS	ROOT
,	,	punct
Purdue	NNP	compound
Pharma	NNP	compound
L.P.	NNP	appos
,	,	punct
the	DT	compound
P.F.	NNP	compound
Laboratories	NNPS	conj
,	,	punct
Inc.	NNP	conj
,	,	punct
Purdue	NNP	compound
Pharmaceuticals	NNPS	compound
L.P.	NNP	conj
,	,	punct
and	CC	cc
Rhodes	NNP	compound
Technologies	NNP	conj
(	-LRB-	punct
collectively	RB	advmod
,	,	punct
"	``	punct
Purdue	NNP	appos
"	''	punct
)	-RRB-	punct
and	CC	cc
Grunenthal	NNP	compound
GmbH	NNP	conj

(	-LRB-	punct
"	``	punct
Grunenthal	NNP	nsubj
"	''	punct
)	-RRB-	punct
assert	VBD	ROOT
a	DT	det
number	NN	dobj
of	IN	prep
claim	NNS	pobj
from	IN	prep
multiple	JJ	amod
different	JJ	amod
patent	NNS	pobj
against	IN	prep
the	DT	det
Appellees	NNPS	pobj
,	,	punct
Amneal	NNP	compound
Pharmaceuticals	NNPS	conj
,	,	punct
LLC	NNP	conj
(	-LRB-	punct
"	``	punct
Amneal	NNP	appos
"	''	punct
)	-RRB-	punct
,	,	punct
Epic	NNP	compound
Pharma	NNP	appos
,	,	punct
LLC	NNP	appos
(	-LRB-	punct
"	``	punct
Epic	NNP	appos
"	''	punct
)	-RRB-	punct
,	,	punct
Mylan	NNP	compound
Pharmaceuticals	NNPS	compound
Inc.	NNP	conj
and	CC	cc
Mylan	NNP	compound
Inc.	NNP	conj
(	-LRB-	punct
collectively	RB	advmod
,	,	punct
"	``	punct
Mylan	NNP	appos
"	''	punct
)	-RRB-	punct
,	,	punct
and	CC	cc
Teva	NNP	compound
Pharmaceuticals	NNPS	compound
USA	NNP	conj
,	,	punct
Inc.	NNP	appos

(	-LRB-	punct
"	``	punct
Teva	NNP	nsubj
"	''	punct
)	-RRB-	punct
,	,	punct
all	DT	nsubj
of	IN	prep
whom	WP	pobj
have	VBP	aux
file	VBN	relcl
Abbreviated	NNP	amod
New	NNP	compound
Drug	NNP	compound
Applications	NNPS	dobj
(	-LRB-	punct
"	``	punct
anda	NNS	appos
"	''	punct
)	-RRB-	punct
seek	VBG	ROOT
to	TO	aux
sell	VB	xcomp
generic	JJ	amod
version	NNS	dobj
of	IN	prep
OxyContin	NNP	pobj
(r)	SYM	intj
.	.	punct

the	DT	det
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	nsubj
for	IN	prep
the	DT	det
Southern	NNP	compound
District	NNP	pobj
of	IN	prep
New	NNP	compound
York	NNP	pobj
hold	VBD	ROOT
a	DT	det
three	CD	nummod
-	HYPH	punct
week	NN	compound
bench	NN	compound
trial	NN	dobj
in	IN	prep
the	DT	det
case	NN	pobj
against	IN	prep
Teva	NNP	pobj
,	,	punct
follow	VBG	prep
which	WDT	pobj
-PRON-	PRP	nsubj
hold	VBD	advcl
all	DT	dobj
of	IN	prep
the	DT	det
asserted	JJ	amod
patent	NN	compound
claim	NNS	pobj
invalid	JJ	advcl
.	.	punct

In	IN	ROOT
re	IN	pobj
OxyContin	NNP	compound
Antitrust	NNP	compound
Litig	NNP	pobj
.	.	punct
,	,	punct
994	CD	nummod
F.Supp.2d	NNP	dep
367	CD	nummod
,	,	punct
377	CD	appos
(	-LRB-	punct
S.D.N.Y.2014	NNP	prep
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
District	NNP	compound
Court	NNP	compound
Decision	NNP	pobj
"	punct	punct
-RRB-	punct	punct
.	.	punct

the	DT	det
court	NN	nsubj
then	RB	advmod
enter	VBD	ROOT
order	NNS	dobj
of	IN	prep
dismissal	NN	pobj
in	IN	prep
the	DT	det
three	CD	nummod
remain	VBG	amod
case	NNS	pobj
against	IN	prep
Amneal	NNP	pobj
,	,	punct
Epic	NNP	conj
,	,	punct
and	CC	cc
Mylan	NNP	conj
base	VBN	prep
on	IN	prep
collateral	JJ	amod
estoppel	NN	pobj
.	.	punct

Purdue	NNP	nsubj
and	CC	cc
Grunenthal	NNP	conj
appeal	VBP	ROOT
the	DT	det
final	JJ	amod
judgment	NN	dobj
in	IN	prep
the	DT	det
Teva	NNP	compound
action	NN	pobj
,	,	punct
and	CC	cc
Purdue	NNP	nsubj
also	RB	advmod
appeal	VBZ	conj
the	DT	det
order	NNS	dobj
of	IN	prep
dismissal	NN	pobj
in	IN	prep
the	DT	det
three	CD	nummod
other	JJ	amod
case	NNS	pobj
.	.	punct

For	IN	prep
the	DT	det
reason	NNS	pobj
state	VBN	acl
below	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
affirm	VBP	ROOT
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
ruling	NNS	dobj
.	.	punct

 	_SP	

Oxycodone	NNP	compound
hydrochloride	NN	nsubj
-	:	punct
the	DT	det
active	JJ	amod
pharmaceutical	NN	amod
ingredient	NN	nsubj
(	-LRB-	punct
"	``	punct
API	NNP	appos
"	''	punct
)	-RRB-	punct
in	IN	prep
OxyContin	NNP	pobj
(r)	SYM	pobj
-	:	punct
be	VBZ	ROOT
an	DT	det
opioid	NN	amod
analgesic	NN	attr
use	VBN	acl
to	TO	aux
treat	VB	xcomp
moderate	JJ	acomp
to	IN	prep
severe	JJ	amod
pain	NN	pobj
.	.	punct

This	DT	det
consolidated	JJ	amod
appeal	NN	nsubj
concern	VBZ	ROOT
four	CD	nummod
patent	NNS	dobj
associate	VBN	acl
with	IN	prep
the	DT	det
reformulate	VBN	amod
version	NN	pobj
of	IN	prep
OxyContin	NNP	pobj
(r)	SYM	punct
:	:	punct

U.S.	NNP	compound
patent	NN	compound
No.	SYM	compound
7,674,799	CD	ROOT
(	-LRB-	punct
"	``	punct
��799	NN	compound
patent	NN	appos
"	''	punct
)	-RRB-	punct
,	,	punct
U.S.	NNP	compound
patent	NN	compound
No.	SYM	appos
7,674,800	CD	nummod
(	-LRB-	punct
"	``	punct
��800	NNP	intj
patent	NN	appos
"	''	punct
)	-RRB-	punct
,	,	punct
U.S.	NNP	compound
patent	NN	compound
No.	SYM	compound
7,683,072	CD	appos
(	-LRB-	punct
"	``	punct
��072	NN	compound
patent	NN	appos
"	''	punct
)	-RRB-	punct
(	-LRB-	punct
collectively	RB	advmod
,	,	punct
"	''	punct
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
patent	NNS	appos
"	''	punct
)	-RRB-	punct
,	,	punct
and	CC	cc
U.S.	NNP	compound
patent	NN	nmod
No.	SYM	compound
8,114,383	CD	nummod
patent	NN	conj
(	-LRB-	punct
"	``	punct
��383	ADD	compound
patent	NN	appos
"	''	punct
)	-RRB-	punct
.	.	punct

 	_SP	

i.	NN	ROOT

the	DT	det
low	JJ	compound
-	HYPH	punct
ABUK	NNP	compound
Patents	NNPS	ROOT

 	_SP	

the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
patent	NNS	nsubj
recite	VBP	ROOT
an	DT	det
improve	VBN	amod
formulation	NN	dobj
of	IN	prep
oxycodone	NN	compound
hydrochloride	NN	pobj
.	.	punct

Those	DT	det
patent	NNS	nsubj
describe	VBP	ROOT
an	DT	det
oxycodone	NN	compound
salt	NN	dobj
with	IN	prep
extremely	RB	advmod
low	JJ	amod
level	NNS	pobj
of	IN	prep
a	DT	det
particular	JJ	amod
impurity	NN	pobj
,	,	punct
14-hydroxycodeinone	JJ	punct
(	-LRB-	punct
"	``	punct
14-hydroxy	JJ	appos
"	''	punct
)	-RRB-	punct
,	,	punct
which	WDT	nsubj
belong	VBZ	relcl
to	IN	prep
a	DT	det
class	NN	pobj
of	IN	prep
potentially	RB	advmod
dangerous	JJ	amod
compound	NNS	pobj
know	VBN	acl
as	IN	prep
alpha	NN	pobj
,	,	punct
beta	NN	nsubj
unsaturated	JJ	amod
ketone	NNS	conj
(	-LRB-	punct
"	``	punct
abuk	NNS	appos
"	''	punct
)	-RRB-	punct
.	.	punct

the	DT	det
prior	JJ	amod
art	NN	compound
method	NN	nsubj
of	IN	prep
synthesize	VBG	pcomp
oxycodone	NN	compound
hydrochloride	NN	dobj
involve	VBD	ROOT
three	CD	nummod
step	NNS	dobj
:	:	punct

first	RB	advmod
,	,	punct
thebaine	NN	nsubjpass
,	,	punct
a	DT	det
derivative	NN	appos
of	IN	prep
the	DT	det
opium	NN	compound
poppy	NN	pobj
,	,	punct
be	VBD	auxpass
oxidize	VBN	ROOT
to	TO	aux
form	VB	xcomp

14-hydroxy	JJ	punct
;	:	punct
second	JJ	advmod
,	,	punct
the	DT	det
14-hydroxy	JJ	nsubjpass
be	VBD	auxpass
convert	VBN	ROOT
to	IN	aux
oxycodone	NN	advcl
free	JJ	amod
base	NN	dobj
through	IN	prep
hydrogenation	NN	pobj
;	:	punct
and	CC	cc
third	RB	advmod
,	,	punct
the	DT	det
oxycodone	NN	nmod
free	JJ	amod
base	NN	nsubjpass
be	VBD	auxpass
react	VBN	conj
with	IN	prep
hydrochloric	JJ	amod
acid	NN	pobj
to	TO	aux
form	VB	advcl
oxycodone	NN	compound
hydrochloride	NN	dobj
.	.	punct

the	DT	det
end	NN	compound
product	NN	nsubj
create	VBN	acl
by	IN	agent
that	DT	det
process	NN	pobj
,	,	punct
however	RB	advmod
,	,	punct
contain	VBD	ROOT
high	JJ	amod
level	NNS	dobj
of	IN	prep
14-hydroxy	JJ	punct
,	,	punct
on	IN	prep
the	DT	det
order	NN	pobj
of	IN	prep
1500	CD	nummod
part	NNS	pobj
per	IN	prep
million	CD	pobj
(	-LRB-	punct
"	``	punct
ppm	FW	npadvmod
"	''	punct
)	-RRB-	punct
.	.	punct

 	_SP	

In	IN	prep
January	NNP	pobj
2004	CD	nummod
,	,	punct
the	DT	det
U.S.	NNP	nmod
Food	NNP	nmod
and	CC	cc
Drug	NNP	conj
Administration	NNP	nsubj
(	-LRB-	punct
"	``	punct
FDA	NNP	appos
"	''	punct
)	-RRB-	punct
become	VBD	ROOT
concerned	JJ	acomp
that	IN	mark
14-hydroxy	JJ	nsubj
be	VBD	ccomp
potentially	RB	advmod
toxic	JJ	acomp
and	CC	cc
thus	RB	advmod
mandate	VBN	conj
that	IN	mark
oxycodone	NN	compound
hydrochloride	NN	compound
manufacturer	NNS	nsubj
either	CC	preconj
provide	VBP	ccomp
evidence	NN	dobj
that	IN	mark
the	DT	det
14-hydroxy	JJ	nummod
level	NNS	nsubj
in	IN	prep
-PRON-	PRP$	poss
formulation	NNS	pobj
be	VBD	acl
safe	JJ	acomp
or	CC	cc
reduce	VB	conj
the	DT	det
amount	NN	dobj
of	IN	prep
14-hydroxy	JJ	quantmod
to	IN	quantmod
less	JJR	amod
than	IN	quantmod
10	CD	nummod
ppm	NNS	pobj
.	.	punct

even	RB	advmod
before	IN	prep
the	DT	det
FDA	NNP	poss
's	POS	case
mandate	NN	pobj
,	,	punct
however	RB	advmod
,	,	punct
Rhodes	NNP	compound
Technologies	NNPS	nsubj
-	:	punct
a	DT	det
subsidiary	NN	appos
of	IN	prep
Purdue	NNP	pobj
-	HYPH	punct
have	VBD	aux
begin	VBN	ROOT
research	VBG	xcomp
method	NNS	dobj
to	TO	aux
reduce	VB	acl
14-hydroxy	JJ	nummod
level	NNS	dobj
in	IN	prep
-PRON-	PRP$	poss
oxycodone	NN	compound
api	NN	pobj
.	.	punct

the	DT	det
scientist	NNS	nsubj
initially	RB	advmod
hypothesize	VBD	ROOT
that	IN	mark
the	DT	det
14-hydroxy	JJ	nummod
present	NN	nsubj
in	IN	prep
the	DT	det
final	JJ	amod
salt	NN	pobj
be	VBD	ccomp
leftover	RB	advmod
14-hydroxy	JJ	pobj
that	WDT	nsubjpass
have	VBD	aux
not	RB	neg
be	VBN	auxpass
hydrogenate	VBN	relcl
in	IN	prep
the	DT	det
second	JJ	amod
step	NN	pobj
.	.	punct

thus	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
extend	VBD	ROOT
the	DT	det
hydrogenation	NN	compound
reaction	NN	dobj
to	IN	prep
completion	NN	pobj
,	,	punct
confirm	VBG	advcl
that	IN	mark
every	DT	det
molecule	NN	nsubj
of	IN	prep
14-hydroxy	JJ	pobj
convert	VBN	ccomp
to	IN	aux
oxycodone	NN	xcomp
free	JJ	amod
base	NN	dobj
at	IN	prep
step	NN	pobj
two	CD	nummod
.	.	punct

but	CC	cc
the	DT	det
scientist	NNS	nsubj
find	VBD	ROOT
that	IN	mark
after	IN	prep
step	NN	pobj
three	CD	advmod
-	HYPH	punct
transform	VBG	pcomp
the	DT	det
oxycodone	NN	nmod
free	JJ	amod
base	NN	dobj
into	IN	prep
oxycodone	NN	compound
hydrochloride	NN	pobj
-	,	punct
the	DT	det
14-hydroxy	JJ	nsubj
have	VBD	aux
return	VBN	ccomp
.	.	punct

 	_SP	

the	DT	det
scientist	NNS	nsubj
thus	RB	advmod
shift	VBD	ROOT
-PRON-	PRP$	poss
focus	NN	dobj
to	TO	aux
step	VB	xcomp
three	CD	dobj
.	.	punct

-PRON-	PRP	nsubj
be	VBD	ROOT
well	RB	advmod
know	VBN	acomp
in	IN	prep
the	DT	det
art	NN	pobj
that	WDT	punct
an	DT	det
impurity	NN	npadvmod
,	,	punct
8,14-dihydroxy-7	CD	appos
,	,	punct

8-dihydrocodeinone	CD	punct
(	-LRB-	punct
"	``	punct
8,14-dihydroxy	CD	nsubjpass
"	''	punct
)	-RRB-	punct
be	VBD	auxpass
produce	VBN	ROOT
as	IN	prep
a	DT	det
byproduct	NN	pobj
of	IN	prep
the	DT	det
oxidation	NN	pobj
of	IN	prep
thebaine	NN	pobj
(	-LRB-	punct
step	VB	compound
one	CD	appos
)	-RRB-	punct
.	.	punct

more	RBR	advmod
specifically	RB	advmod
,	,	punct
-PRON-	PRP	nsubjpass
be	VBD	auxpass
know	VBN	ROOT
that	IN	mark
a	DT	det
particular	JJ	amod
isomer	NN	nsubjpass
of	IN	prep
8,14-dihydroxy	CD	pobj
be	VBD	auxpass
form	VBN	ccomp
:	:	punct

8�]	NNP	ROOT
,	,	punct
14-dihydroxy-7	CD	npadvmod
,	,	punct

8-dihydrocodeinone	CD	punct
(	-LRB-	punct
"	``	punct
8�]	NNP	ROOT
"	''	punct
)	-RRB-	punct
.	.	punct

scientist	NNS	nsubj
do	VBD	aux
not	RB	neg
know	VB	ROOT
with	IN	prep
certainty	NN	pobj
,	,	punct
however	RB	advmod
,	,	punct
whether	IN	mark
8�\,14-dihydroxy-7	JJ	ccomp
,	,	punct

8-dihydrocodeinone	CD	subtok
(	-LRB-	punct
"	``	punct
8�\")-a	NNP	compound
diastereomer	NN	nsubj
of	IN	prep
8�\-was	CD	pobj
also	RB	advmod
produce	VBN	ccomp
during	IN	prep
the	DT	det
oxidation	NN	compound
step	NN	pobj
.	.	punct
Purdue	NNP	compound
scientist	NNS	nsubj
have	VBD	aux
previously	RB	advmod
note	VBN	ccomp
the	DT	det
potential	JJ	amod
existence	NN	dobj
of	IN	prep
8�\	NN	pobj
,	,	punct
but	CC	cc
no	DT	det
scientific	JJ	amod
literature	NN	nsubj
discuss	VBD	conj
that	IN	det
particular	JJ	amod
isomer	NN	dobj
.	.	punct
through	IN	prep
experimentation	NN	pobj
,	,	punct
the	DT	det
scientist	NNS	nsubj
determine	VBD	ccomp
that	IN	mark
8�\	NN	nsubjpass
be	VBD	aux
indeed	RB	advmod
be	VBG	auxpass
produce	VBN	ccomp
at	IN	prep
step	NN	pobj
one	CD	nummod
and	CC	cc
,	,	punct
in	IN	prep
fact	NN	pobj
,	,	punct
be	VBD	aux
transform	VBG	conj
into	IN	prep
14-hydroxy	JJ	pobj
during	IN	prep
the	DT	det
acid	NN	npadvmod
-	HYPH	punct
catalyze	VBN	amod
dehydration	NN	pobj
at	IN	prep
step	NN	pobj
three	CD	nummod
.	.	punct
to	TO	aux
remove	VB	advcl
the	DT	det
14-hydroxy	JJ	dobj
from	IN	prep
the	DT	det
oxycodone	NN	compound
api	NN	pobj
,	,	punct
the	DT	det
scientist	NNS	nsubj
add	VBD	ROOT
another	DT	det
hydrogenation	NN	compound
step	NN	dobj
at	IN	prep
the	DT	det
end	NN	pobj
of	IN	prep
step	NN	pobj
three	CD	nummod
to	TO	aux
convert	VB	advcl
the	DT	det
remain	VBG	amod
14-hydroxy	JJ	dobj
into	IN	prep
oxycodone	NN	nmod
free	JJ	amod
base	NN	pobj
.	.	punct
By	IN	prep
June	NNP	pobj
2003	CD	nummod
,	,	punct
Rhodes	NNP	poss
's	POS	case
laboratory	NN	nsubj
could	MD	aux
routinely	RB	advmod
produce	VB	ccomp
oxycodone	NN	compound
api	NN	dobj
with	IN	prep
14-hydroxy	JJ	nummod
level	NNS	pobj
less	JJR	amod
than	IN	quantmod
10	CD	nummod
ppm	NNS	dobj
use	VBG	advcl
the	DT	det
double	JJ	amod
-	HYPH	punct
hydrogenation	NN	compound
process	NN	dobj
.	.	punct
Purdue	NNP	nsubj
and	CC	cc
Rhodes	NNP	conj
thus	RB	advmod
seek	VBD	conj
approval	NN	dobj
from	IN	prep
the	DT	det
FDA	NNP	nmod
and	CC	cc
patent	NN	conj
protection	NN	pobj
for	IN	prep
-PRON-	PRP$	poss
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	compound
product	NN	pobj
.	.	punct

 	_SP	
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
patent	NNS	nsubj
continue	VBP	ccomp
from	IN	prep
application	NN	compound
No.	SYM	pobj
11/391,897	CD	nummod
,	,	punct
know	VBN	acl
as	IN	prep
the	DT	det
"	``	punct
Chapman	NNP	compound
Application	NNP	pobj
"	''	punct
.	.	punct
the	DT	det
claim	NNS	nsubj
of	IN	prep
the	DT	det
Chapman	NNP	compound
Application	NNP	pobj
have	VBP	aux
previously	RB	advmod
be	VBN	ccomp
before	IN	prep
-PRON-	PRP	pobj
;	:	punct
-PRON-	PRP	nsubj
author	VBD	advcl
a	DT	det
non	JJ	subtok
-	JJ	subtok
precedential	JJ	amod
decision	NN	dobj
affirm	VBG	acl
the	DT	det
Board	NNP	dobj
of	IN	prep
Patent	NNP	compound
Appeals	NNPS	pobj
and	CC	cc
Interferences	NNPS	poss
'	POS	case
determination	NN	conj
that	IN	mark
the	DT	det
Chapman	NNP	compound
claim	NNS	nsubj
be	VBD	acl
obvious	JJ	acomp
.	.	punct
Chapman	NNP	dobj
v.	IN	prep
Casner	NNP	pobj
,	,	punct
315	CD	nummod
Fed	NNP	appos
.	.	punct
appx	NN	dobj
.	.	punct
294	CD	npadvmod
,	,	punct
295	CD	nummod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2009	LS	appos
)	-RRB-	punct
(	-LRB-	punct
rader	NN	ccomp
,	,	punct
CJ	NNP	npadvmod
.	.	punct
,	,	punct
dissent	VBG	acl
)	-RRB-	punct
.	.	punct
In	IN	prep
that	DT	det
case	NN	pobj
,	,	punct
the	DT	det
Board	NNP	nsubj
declare	VBD	ccomp
an	DT	det
interference	NN	dobj
between	IN	prep
the	DT	det
Chapman	NNP	compound
Application	NNP	pobj
and	CC	cc
U.S.	NNP	compound
patent	NN	compound
No.	SYM	conj
7,153,966	CD	nummod
(	-LRB-	punct
"	``	punct
Casner	NNP	oprd
"	''	punct
)	-RRB-	punct
.	.	punct
the	DT	det
relevant	JJ	amod
claim	NNS	nsubj
in	IN	prep
the	DT	det
Chapman	NNP	compound
Application	NNP	pobj
relate	VBN	ccomp
to	IN	prep
a	DT	det
method	NN	pobj
for	IN	prep
make	VBG	pcomp
oxycodone	NN	compound
API	NNP	nsubj
use	VBG	ccomp
a	DT	det
hydrogenation	NN	compound
step	NN	dobj
to	TO	aux
remove	VB	xcomp
14-hydroxy	JJ	dobj
,	,	punct
but	CC	cc
-PRON-	PRP	nsubj
do	VBD	aux
not	RB	neg
require	VB	conj
that	IN	mark
some	DT	nsubjpass
of	IN	prep
the	DT	det
remain	VBG	amod
14-hydroxy	JJ	pobj
be	VB	auxpass
derive	VBN	ccomp
from	IN	prep
the	DT	det
8�\	JJ	amod
isomer	NN	pobj
.	.	punct
Idaho	NNP	compound
the	DT	det
Board	NNP	nsubj
compare	VBD	advcl
Chapman	NNP	poss
's	POS	case
claim	NNS	dobj
to	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
and	CC	cc
conclude	VBD	conj
that	IN	mark
-PRON-	PRP	nsubj
be	VBD	ccomp
obvious	JJ	acomp
.	.	punct
Chapman	NNP	nsubj
appeal	VBD	ccomp
directly	RB	advmod
to	IN	prep
-PRON-	PRP	pobj
,	,	punct
and	CC	cc
-PRON-	PRP	nsubj
agree	VBD	conj
with	IN	prep
the	DT	det
Board	NNP	pobj
.	.	punct
-PRON-	PRP	nsubj
reason	VBD	ccomp
that	IN	dobj
,	,	punct
because	IN	mark
the	DT	det
claim	NNS	nsubj
do	VBD	aux
not	RB	neg
specify	VB	advcl
the	DT	det
source	NN	dobj
of	IN	prep
the	DT	det
14-hydroxy	JJ	pobj
,	,	punct
any	DT	det
prior	JJ	amod
art	NN	compound
reference	NN	appos
that	WDT	nsubj
disclose	VBD	relcl
condition	NNS	dobj
under	IN	prep
which	WDT	pobj
either	CC	preconj
8�\	JJ	nsubj
or	CC	cc
8�]	NN	conj
convert	VBD	relcl
to	IN	prep
14-hydroxy	JJ	pobj
would	MD	aux
render	VB	ccomp
the	DT	det
claim	NN	nsubj
obvious	JJ	ccomp
.	.	punct
Idaho	NNS	dobj
at	IN	prep
297	CD	pobj
.	.	punct
-PRON-	PRP	nsubj
further	RB	advmod
note	VBD	conj
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	nsubj
do	VBD	ccomp
just	RB	advmod
that	DT	dobj
-	:	punct
-PRON-	PRP	nsubj
disclose	VBD	ccomp
the	DT	det
conversion	NN	dobj
of	IN	prep
8�]	NN	pobj
to	TO	prep
14-hydroxy	JJ	pobj
under	IN	prep
certain	JJ	amod
condition	NNS	pobj
.	.	punct
Idaho	NNP	compound
thus	RB	advmod
-PRON-	PRP	nsubj
affirm	VBD	ccomp
the	DT	det
Board	NNP	poss
's	POS	case
decision	NN	dobj
to	TO	aux
reject	VB	acl
the	DT	det
Chapman	NNP	compound
claim	NNS	ccomp
as	RB	prep
obvious	JJ	amod
.	.	punct
Idaho	NNS	dobj
at	IN	prep
297	CD	pobj
-	SYM	punct
98	CD	prep
.	.	punct

 	_SP	
Purdue	NNP	nsubj
eventually	RB	advmod
amend	VBD	ccomp
the	DT	det
Chapman	NNP	compound
claim	NNS	dobj
to	TO	aux
include	VB	xcomp
the	DT	det
claim	NNS	dobj
now	RB	advmod
on	IN	prep
appeal	NN	pobj
.	.	punct
unlike	IN	prep
the	DT	det
claim	NNS	pobj
in	IN	prep
the	DT	det
Chapman	NNP	compound
Application	NNP	pobj
,	,	punct
the	DT	det
claim	NNS	nsubj
at	IN	prep
issue	NN	pobj
here	RB	advmod
be	VBP	ccomp
product	NN	compound
claim	NNS	attr
instead	RB	advmod
of	IN	cc
process	NN	compound
claim	NNS	conj
,	,	punct
and	CC	cc
-PRON-	PRP	nsubj
explicitly	RB	advmod
recite	VBP	conj
8�\	NN	dobj
as	IN	prep
the	DT	det
source	NN	pobj
of	IN	prep
at	IN	advmod
least	JJS	advmod
a	DT	det
portion	NN	pobj
of	IN	prep
the	DT	det
minimal	JJ	amod
amount	NNS	pobj
of	IN	prep
14-hydroxy	JJ	nsubj
remain	VBG	pcomp
in	IN	prep
the	DT	det
oxycodone	NN	compound
api	NN	pobj
.	.	punct
In	IN	prep
2010	CD	pobj
,	,	punct
the	DT	det
U.S.	NNP	nmod
Patent	NNP	nmod
and	CC	cc
Trademark	NNP	conj
Office	NNP	nsubj
allow	VBD	ccomp
the	DT	det
claim	NNS	dobj
and	CC	cc
issue	VBD	conj
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
patent	NNS	dobj
.	.	punct

 	_SP	
II	NNP	dobj
.	.	punct
the	DT	det
��383	DT	nsubj
patent	NN	conj

 	_SP	
the	DT	det
��383	DT	compound
patent	NN	nsubj
cover	VBZ	conj
abuse	NN	npadvmod
-	HYPH	punct
resistant	JJ	amod
formulation	NNS	dobj
.	.	punct
Original	NNP	amod
OxyContin	NNP	subtok
(r)	SYM	nsubj
be	VBD	ccomp
a	DT	det
popular	JJ	amod
opioid	NN	amod
analgesic	NN	attr
which	WDT	nsubj
deliver	VBD	relcl
a	DT	det
large	JJ	amod
dose	NN	dobj
of	IN	prep
oxycodone	NN	pobj
over	IN	prep
a	DT	det
twelve	CD	nummod
-	HYPH	punct
hour	NN	compound
period	NN	pobj
.	.	punct
In	IN	prep
the	DT	det
early	JJ	amod
2000	NNS	pobj
,	,	punct
however	RB	advmod
,	,	punct
report	NNS	nsubj
of	IN	prep
widespread	JJ	amod
abuse	NN	pobj
of	IN	prep
Original	NNP	compound
OxyContin	NNP	pobj
(r)	SYM	nsubj
emerge	VBD	ccomp
,	,	punct
and	CC	cc
the	DT	det
problem	NN	nsubj
begin	VBD	conj
to	TO	aux
garner	VB	xcomp
significant	JJ	amod
public	JJ	amod
attention	NN	dobj
.	.	punct
Original	NNP	amod
OxyContin	NNP	subtok
(r)	SYM	nsubj
be	VBD	conj
susceptible	JJ	acomp
to	IN	prep
tamper	VBG	pcomp
because	IN	mark
abuser	NNS	nsubj
could	MD	aux
crush	VB	advcl
the	DT	det
tablet	NNS	dobj
easily	RB	advmod
into	IN	prep
powder	NN	pobj
,	,	punct
which	WDT	nsubjpass
could	MD	aux
then	RB	advmod
be	VB	auxpass
swallow	VBN	relcl
,	,	punct
snort	VBN	conj
,	,	punct
or	CC	cc
inject	VBD	conj
for	IN	prep
an	DT	det
instant	JJ	pobj
opioid	NN	amod
"	``	punct
high	JJ	amod
"	''	punct
.	.	punct
In	IN	prep
2001	CD	pobj
,	,	punct
Purdue	NNP	nsubj
and	CC	cc
the	DT	det
FDA	NNP	conj
change	VBD	conj
the	DT	det
label	NN	dobj
of	IN	prep
Original	NNP	compound
OxyContin	NNP	pobj
(r)	SYM	advcl
to	TO	aux
warn	VB	advcl
doctor	NNS	dobj
about	IN	prep
the	DT	det
potential	NN	pobj
for	IN	mark
abuser	NNS	nsubj
to	TO	aux
tamper	VB	advcl
with	IN	prep
the	DT	det
dosage	NN	compound
form	NN	pobj
.	.	punct

 	_SP	
Purdue	NNP	nsubj
thus	RB	advmod
investigate	VBD	conj
way	NNS	dobj
to	TO	aux
reformulate	VB	relcl
OxyContin	NNP	compound
(r)	SYM	dobj
to	TO	aux
deter	VB	advcl
abuse	NN	dobj
.	.	punct
Purdue	NNP	nsubj
initially	RB	advmod
consider	VBD	ccomp
,	,	punct
among	IN	prep
other	JJ	amod
idea	NNS	pobj
,	,	punct
create	VBG	advcl
a	DT	det
tablet	NN	dobj
that	WDT	nsubj
would	MD	aux
be	VB	relcl
difficult	JJ	acomp
to	TO	aux
crush	VB	xcomp
and	CC	cc
difficult	JJ	conj
to	TO	aux
inject	VB	xcomp
,	,	punct
but	CC	cc
those	DT	det
effort	NNS	nsubj
be	VBD	conj
unsuccessful	JJ	acomp
.	.	punct
In	IN	prep
2003	CD	pobj
,	,	punct
Purdue	NNP	nsubj
become	VBD	conj
aware	JJ	acomp
of	IN	prep
technology	NN	pobj
develop	VBN	acl
by	IN	agent
Grunenthal	NNP	pobj
that	WDT	nsubj
make	VBD	relcl
tablet	NNS	nsubj
extremely	RB	advmod
hard	RB	ccomp
(	-LRB-	punct
in	IN	prep
order	NN	pobj
to	TO	aux
prevent	VB	acl
crushing	NN	dobj
)	-RRB-	punct
and	CC	cc
form	VBD	conj
a	DT	det
gel	NN	dobj
upon	IN	prep
dissolution	NN	pobj
in	IN	prep
water	NN	pobj
(	-LRB-	punct
in	IN	prep
order	NN	pobj
to	TO	aux
prevent	VB	acl
inject	VBG	dobj
)	-RRB-	punct
.	.	punct

 	_SP	
Grunenthal	NNP	nsubj
first	RB	advmod
begin	VBD	ccomp
to	TO	aux
research	VB	xcomp
abuse	NN	nmod
resistant	JJ	amod
property	NNS	dobj
for	IN	prep
-PRON-	PRP$	poss
opioid	JJ	amod
product	NN	pobj
,	,	punct
tapentadol	RB	advmod
.	.	punct
In	IN	prep
October	NNP	pobj
2002	CD	nummod
,	,	punct
Johnson	NNP	nsubj
&	CC	cc
Johnson	NNP	conj
propose	VBD	conj
a	DT	det
joint	JJ	amod
venture	NN	dobj
with	IN	prep
Grunenthal	NNP	pobj
,	,	punct
use	VBG	advcl
Johnson	NNP	poss
&	CC	cc
Johnson	NNP	conj
's	POS	case
osmotically	RB	amod
control	VBN	amod
-	HYPH	punct
release	NN	nmod
oral	JJ	amod
delivery	NN	compound
system	NN	dobj
(	-LRB-	punct
"	``	punct
OROS	NNP	appos
"	''	punct
)	-RRB-	punct
to	TO	aux
deter	VB	xcomp
abuse	NN	dobj
.	.	punct
the	DT	det
OROS	NNP	compound
technology	NN	nsubj
consist	VBZ	conj
of	IN	prep
a	DT	det
tablet	NN	pobj
with	IN	prep
an	DT	det
outer	JJ	amod
shell	NN	pobj
that	WDT	nsubj
limit	VBZ	relcl
the	DT	det
flow	NN	dobj
of	IN	prep
the	DT	det
api	NN	pobj
from	IN	prep
an	DT	det
inner	JJ	amod
core	NN	pobj
through	IN	prep
the	DT	det
use	NN	pobj
of	IN	prep
a	DT	det
"	``	punct
push	NN	compound
compartment	NN	pobj
"	''	punct
in	IN	prep
the	DT	det
tablet	NN	pobj
.	.	punct
the	DT	det
hard	JJ	amod
outer	JJ	amod
shell	NN	nsubjpass
be	VBZ	auxpass
compose	VBN	ccomp
of	IN	prep
high	JJ	amod
molecular	JJ	amod
weight	NN	compound
polyethylene	NN	compound
oxide	NN	pobj
(	-LRB-	punct
"	``	punct
PEO	NNP	appos
"	''	punct
)	-RRB-	punct
,	,	punct
and	CC	cc
the	DT	det
"	``	punct
push	NN	compound
compartment	NN	nsubj
"	''	punct
expand	VBZ	conj
to	TO	aux
force	VB	xcomp
the	DT	det
api	NN	dobj
through	IN	prep
a	DT	det
hole	NN	pobj
in	IN	prep
the	DT	det
outer	JJ	amod
shell	NN	pobj
.	.	punct
but	CC	cc
the	DT	det
tablet	NN	nsubjpass
could	MD	aux
still	RB	advmod
be	VB	auxpass
easily	RB	advmod
crush	VBN	ccomp
with	IN	prep
a	DT	det
mortar	NN	pobj
and	CC	cc
pestle	NN	conj
,	,	punct
so	RB	cc
-PRON-	PRP	nsubj
be	VBD	conj
not	RB	neg
a	DT	det
workable	JJ	amod
solution	NN	attr
.	.	punct
Dr.	NNP	compound
Johannes	NNP	compound
Bartholomaeus	NNP	nsubj
,	,	punct
who	WP	nsubj
be	VBD	relcl
the	DT	det
head	NN	attr
of	IN	prep
pharmaceutical	JJ	amod
development	NN	pobj
for	IN	prep
Grunenthal	NNP	pobj
at	IN	prep
the	DT	det
time	NN	pobj
,	,	punct
try	VBD	conj
to	TO	aux
strengthen	VB	xcomp
tapentadol	NN	poss
's	POS	case
dosage	NN	compound
form	NN	dobj
by	IN	prep
make	VBG	pcomp
the	DT	det
entire	JJ	amod
tablet	NN	dobj
,	,	punct
instead	RB	advmod
of	IN	prep
just	RB	advmod
the	DT	det
outer	JJ	amod
shell	NN	pobj
,	,	punct
resistant	JJ	advmod
to	IN	prep
crush	VBG	pcomp
.	.	punct
Dr.	NNP	compound
Bartholomaeus	NNP	nsubj
thus	RB	advmod
design	VBD	ccomp
a	DT	det
formulation	NN	dobj
that	WDT	nsubj
contain	VBD	relcl
a	DT	det
matrix	NN	dobj
of	IN	prep
API	NNP	pobj
and	CC	cc
PEO	NNP	conj
throughout	IN	prep
the	DT	det
tablet	NN	pobj
.	.	punct
moreover	RB	advmod
,	,	punct
Dr.	NNP	compound
Bartholomaeus	NNP	poss
's	POS	case
experimentation	NN	nsubj
with	IN	prep
PEO	NNP	pobj
demonstrate	VBD	ccomp
that	IN	mark
use	VBG	csubj
both	DT	det
heat	NN	dobj
and	CC	cc
pressure	NN	conj
to	TO	aux
form	VB	xcomp
the	DT	det
tablet	NN	nsubj
result	VBD	ccomp
in	IN	prep
a	DT	det
strong	JJR	amod
solid	JJ	pobj
that	WDT	nsubj
resist	VBD	relcl
break	VBG	xcomp
by	IN	prep
a	DT	det
hammer	NN	pobj
or	CC	cc
by	IN	conj
a	DT	det
mortar	NN	pobj
and	CC	cc
pestle	NN	conj
,	,	punct
and	CC	cc
withstand	VBD	conj
a	DT	det
break	VBG	amod
strength	NN	compound
test	NN	dobj
that	WDT	nsubj
exert	VBD	relcl
500	CD	nummod
n	CD	dobj
of	IN	prep
force	NN	pobj
.	.	punct

 	_SP	
After	IN	prep
a	DT	det
series	NN	pobj
of	IN	prep
negotiation	NNS	pobj
,	,	punct
Purdue	NNP	nsubj
obtain	VBD	advcl
a	DT	det
license	NN	dobj
from	IN	prep
Grunenthal	NNP	pobj
to	TO	aux
use	VB	advcl
the	DT	det
abuse	NN	compound
deterrent	NN	compound
technology	NN	dobj
of	IN	prep
the	DT	det
��383	DT	compound
patent	NN	pobj
in	IN	prep
-PRON-	PRP$	poss
Reformulated	NNP	compound
OxyContin	NNP	nmod
(r)	SYM	det
product	NN	pobj
.	.	punct
Purdue	NNP	nsubj
submit	VBD	ccomp
a	DT	det
New	NNP	compound
Drug	NNP	compound
Application	NNP	dobj
to	IN	dative
the	DT	det
FDA	NNP	pobj
in	IN	prep
November	NNP	pobj
2007	CD	nummod
,	,	punct
propose	VBG	advcl
a	DT	det
Reformulated	NNP	compound
OxyContin	NNP	compound
(r)	SYM	dobj
,	,	punct
which	WDT	dobj
the	DT	det
FDA	NNP	nsubj
approve	VBD	relcl
in	IN	prep
April	NNP	pobj
2010	CD	nummod
.	.	punct
By	IN	prep
July	NNP	pobj
2012	CD	nummod
,	,	punct
Purdue	NNP	nsubj
note	VBD	conj
reduction	NNS	dobj
in	IN	prep
the	DT	det
abuse	NN	pobj
of	IN	prep
OxyContin	NNP	pobj
(r)	SYM	advmod
and	CC	cc
provide	VBD	conj
that	DT	det
information	NN	dobj
to	IN	dative
the	DT	det
FDA	NNP	pobj
.	.	punct
On	IN	prep
April	NNP	pobj
16	CD	nummod
,	,	punct
2013	CD	appos
,	,	punct
the	DT	det
FDA	NNP	nsubj
withdraw	VBD	ccomp
-PRON-	PRP$	poss
approval	NN	dobj
for	IN	prep
Original	NNP	compound
OxyContin	NNP	subtok
(r)	SYM	pobj
and	CC	cc
stop	VBD	conj
accept	VBG	xcomp
anda	NNS	dobj
that	WDT	nsubj
propose	VBD	relcl
generic	JJ	amod
version	NNS	dobj
of	IN	prep
-PRON-	PRP	pobj
,	,	punct
reason	VBG	prep
that	IN	mark
Reformulated	NNP	compound
OxyContin	NNP	nsubj
(r)	SYM	nsubj
be	VBD	ccomp
available	JJ	acomp
to	TO	aux
provide	VB	xcomp
the	DT	det
same	JJ	amod
benefit	NNS	dobj
with	IN	prep
low	JJR	amod
risk	NNS	pobj
of	IN	prep
abuse	NN	pobj
and	CC	cc
misuse	NN	conj
.	.	punct
On	IN	prep
the	DT	det
same	JJ	amod
day	NN	pobj
,	,	punct
the	DT	det
FDA	NNP	nsubj
approve	VBD	conj
a	DT	det
new	JJ	amod
label	NN	dobj
that	WDT	nsubj
allow	VBD	relcl
Purdue	NNP	nsubj
to	TO	aux
market	VB	ccomp
Reformulated	NNP	compound
OxyContin	NNP	dobj
(r)	SYM	advmod
on	IN	prep
the	DT	det
basis	NN	pobj
of	IN	prep
-PRON-	PRP$	poss
abuse	NN	compound
deterrent	NN	compound
property	NNS	pobj
.	.	punct

 	_SP	
III	NNP	dobj
.	.	punct
procedural	JJ	compound
history	NN	dobj

 	_SP	
In	IN	prep
March	NNP	pobj
2011	CD	nummod
,	,	punct
Purdue	NNP	nsubj
sue	VBD	ccomp
Teva	NNP	dobj
for	IN	prep
infringement	NN	pobj
of	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
patent	NNS	pobj
in	IN	prep
response	NN	pobj
to	IN	prep
Teva	NNP	poss
's	POS	case
filing	NN	pobj
of	IN	prep
an	DT	det
ANDA	NNP	pobj
seek	VBG	acl
FDA	NNP	compound
approval	NN	dobj
to	TO	prep
market	VB	nmod
generic	JJ	amod
version	NNS	pobj
of	IN	prep
Reformulated	NNP	compound
OxyContin	NNP	pobj
(r)	SYM	intj
.	.	punct
between	IN	prep
November	NNP	pobj
2011	CD	nummod
and	CC	cc
January	NNP	conj
2013	CD	nummod
,	,	punct
Purdue	NNP	nsubj
file	VBD	ccomp
similar	JJ	amod
lawsuit	NNS	dobj
against	IN	prep
Epic	NNP	pobj
,	,	punct
Mylan	NNP	conj
,	,	punct
and	CC	cc
Amneal	NNP	conj
.	.	punct
In	IN	prep
addition	NN	pobj
,	,	punct
in	IN	prep
June	NNP	pobj
2012	CD	nummod
,	,	punct
Grunenthal	NNP	nsubj
and	CC	cc
Purdue	NNP	conj
jointly	RB	advmod
sue	VBD	conj
Teva	NNP	dobj
for	IN	prep
infringement	NN	pobj
of	IN	prep
the	DT	det
��	NN	amod
383	CD	nummod
patent	NN	pobj
.	.	punct
the	DT	det
two	CD	nummod
Teva	NNP	compound
case	NNS	nsubjpass
be	VBD	auxpass
consolidate	VBN	advcl
and	CC	cc
join	VBN	conj
with	IN	prep
the	DT	det
Epic	NNP	pobj
,	,	punct
Mylan	NNP	conj
,	,	punct
and	CC	cc
amneal	JJ	conj
case	NNS	conj
,	,	punct
along	IN	prep
with	IN	prep
six	CD	nummod
action	NNS	pobj
involve	VBG	acl
other	JJ	amod
defendant	NNS	dobj
,	,	punct
in	IN	prep
multi	JJ	subtok
-	JJ	subtok
district	JJ	amod
litigation	NN	pobj
for	IN	prep
pretrial	JJ	amod
purpose	NNS	pobj
.	.	punct

 	_SP	
In	IN	prep
September	NNP	pobj
2013	CD	nummod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
hold	VBD	conj
a	DT	det
three	CD	nummod
-	HYPH	punct
week	NN	compound
bench	NN	compound
trial	NN	dobj
in	IN	prep
the	DT	det
Teva	NNP	pobj
cases.1	.	dep
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ccomp
that	IN	mark
the	DT	det
assert	VBN	amod
claim	NNS	nsubjpass
be	VBD	auxpass
infringe	VBN	ccomp
by	IN	agent
Teva	NNP	poss
's	POS	case
propose	VBN	amod
generic	JJ	amod
product	NN	pobj
,	,	punct
but	CC	cc
-PRON-	PRP	nsubj
also	RB	advmod
hold	VBD	conj
that	IN	mark
all	DT	nsubj
of	IN	prep
the	DT	det
claim	NNS	pobj
be	VBD	ccomp
invalid	JJ	acomp
as	IN	mark
anticipate	VBN	advcl
by	IN	prep
or	CC	cc
obvious	JJ	conj
over	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
.	.	punct
District	NNP	compound
Court	NNP	compound
Decision	NNP	dobj
,	,	punct
994	CD	nummod
f.supp.2d	NN	appos
at	IN	prep
377	CD	pobj
.	.	punct
base	VBN	prep
on	IN	prep
that	DT	det
decision	NN	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
issue	VBD	advcl
an	DT	det
order	NN	dobj
for	IN	mark
Purdue	NNP	nsubj
to	TO	aux
show	VB	advcl
cause	NN	dobj
as	IN	prep
to	IN	prep
why	WRB	advmod
the	DT	det
action	NNS	nsubjpass
against	IN	prep
Epic	NNP	pobj
,	,	punct
Mylan	NNP	conj
,	,	punct
and	CC	cc
Amneal	NNP	conj
should	MD	aux
not	RB	neg
be	VB	auxpass
dismiss	VBN	pcomp
under	IN	prep
the	DT	det
doctrine	NN	pobj
of	IN	prep
collateral	JJ	amod
estoppel	NN	pobj
.	.	punct
Purdue	NNP	nsubj
state	VBD	ccomp
that	IN	mark
-PRON-	PRP	nsubj
intend	VBD	ccomp
to	TO	aux
appeal	VB	xcomp
the	DT	det
Teva	NNP	compound
decision	NN	dobj
but	CC	cc
-PRON-	PRP	nsubj
agree	VBD	conj
that	IN	mark
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
decision	NN	nsubj
regard	VBG	prep
the	DT	det
invalidity	NN	pobj
of	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
patent	NNS	pobj
preclude	VBD	ccomp
Purdue	NNP	poss
's	POS	case
claim	NNS	dobj
for	IN	prep
relief	NN	pobj
against	IN	prep
the	DT	det
other	JJ	amod
defendant	NNS	pobj
.	.	punct
accordingly	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
dismiss	VBD	conj
the	DT	det
three	CD	nummod
remain	VBG	amod
action	NNS	dobj
base	VBN	acl
on	IN	prep
collateral	JJ	amod
estoppel	NN	pobj
.	.	punct

 	_SP	
Purdue	NNP	nsubj
and	CC	cc
Grunenthal	NNP	conj
appeal	VBP	ccomp
the	DT	det
final	JJ	amod
judgment	NN	dobj
in	IN	prep
the	DT	det
Teva	NNP	compound
action	NNS	pobj
and	CC	cc
Purdue	NNP	nsubj
also	RB	advmod
appeal	VBZ	conj
the	DT	det
order	NNS	dobj
of	IN	prep
dismissal	NN	pobj
in	IN	prep
the	DT	det
three	CD	nummod
other	JJ	amod
case	NNS	pobj
.	.	punct
-PRON-	PRP	nsubj
have	VBP	ccomp
jurisdiction	NN	dobj
under	IN	prep
28	CD	nummod
U.S.C.	NNP	compound
��	NN	compound
1295(a)(1	CD	pobj
)	-RRB-	punct
.	.	punct

  	_SP	
a	DT	det
patent	NN	nsubj
be	VBZ	ccomp
invalid	JJ	acomp
for	IN	prep
anticipation	NN	pobj
under	IN	prep
35	CD	nummod
u.s.c.	NN	compound
��	NN	pobj
102	CD	nummod
if	IN	mark
a	DT	det
single	JJ	amod
prior	JJ	amod
art	NN	compound
reference	NN	nsubj
disclose	VBZ	advcl
each	DT	dobj
and	CC	cc
every	DT	det
limitation	NN	conj
of	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
.	.	punct
Schering	NNP	compound
Corp.	NNP	dobj
v.	CC	prep
Geneva	NNP	compound
Pharm.	NNP	pobj
,	,	punct
339	CD	nummod
f.3d	CD	appos
1373	CD	appos
,	,	punct
1377	CD	npadvmod

(	-LRB-	punct
Fed	NNP	nsubj
.	.	punct
Cir.2003	NFP	dobj
)	-RRB-	punct
.	.	punct
a	DT	det
single	JJ	amod
prior	JJ	amod
art	NN	compound
reference	NN	nsubj
may	MD	aux
anticipate	VB	advmod
without	IN	prep
disclose	VBG	pcomp
a	DT	det
feature	NN	dobj
of	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
if	IN	mark
such	JJ	amod
feature	NN	nsubj
be	VBZ	advcl
necessarily	RB	advmod
present	JJ	acomp
,	,	punct
or	CC	cc
inherent	JJ	conj
,	,	punct
in	IN	prep
that	DT	det
reference	NN	pobj
.	.	punct
Idaho	NNP	compound
Anticipation	NNP	nsubj
be	VBZ	ccomp
a	DT	det
question	NN	attr
of	IN	prep
fact	NN	pobj
,	,	punct
which	WDT	dobj
-PRON-	PRP	nsubj
review	VBP	relcl
for	IN	prep
clear	JJ	amod
error	NN	pobj
.	.	punct
Atlas	NNP	compound
Powder	NNP	compound
Co.	NNP	dobj
v.	CC	prep
Ireco	NNP	pobj
,	,	punct
Inc.	NNP	appos
,	,	punct
190	CD	nummod
F.3d	NNP	appos
1342	CD	nummod
,	,	punct
1346	CD	npadvmod
(	-LRB-	punct
Fed	NNP	pobj
.	.	punct
Cir.1999	NNP	appos
)	-RRB-	punct
.	.	punct

  	_SP	
a	DT	det
patent	NN	nsubj
be	VBZ	conj
invalid	JJ	acomp
for	IN	prep
obviousness	JJ	pobj
"	''	punct
if	IN	mark
the	DT	det
difference	NNS	nsubj
between	IN	prep
the	DT	det
subject	JJ	amod
matter	NN	pobj
seek	VBD	advcl
to	TO	aux
be	VB	auxpass
patent	VBN	xcomp
and	CC	cc
the	DT	det
prior	JJ	amod
art	NN	nsubj
be	VBP	conj
such	JJ	acomp
that	IN	mark
the	DT	det
subject	JJ	amod
matter	NN	nsubj
as	IN	prep
a	DT	det
whole	NN	pobj
would	MD	aux
have	VB	aux
be	VBN	ccomp
obvious	JJ	acomp
at	IN	prep
the	DT	det
time	NN	pobj
the	DT	det
invention	NN	nsubjpass
be	VBD	auxpass
make	VBN	relcl
to	IN	prep
a	DT	det
person	NN	pobj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
in	IN	prep
the	DT	det
art	NN	pobj
to	IN	prep
which	WDT	nsubj
say	VBD	pcomp
subject	JJ	amod
matter	NN	compound
pertain	VBZ	dobj
"	''	punct
.	.	punct
35	CD	nummod
u.s.c.	NN	compound
��	NN	conj
103(a	CD	npadvmod
)	-RRB-	punct
.	.	punct
Obviousness	NNP	nsubj
be	VBZ	conj
a	DT	det
legal	JJ	amod
conclusion	NN	attr
base	VBN	acl
on	IN	prep
underlie	VBG	amod
fact	NNS	pobj
.	.	punct
Graham	NNP	attr
v.	IN	prep
John	NNP	compound
Deere	NNP	compound
Co.	NNP	pobj
,	,	punct
383	CD	nummod
U.S.	NNP	conj
1	CD	nummod
,	,	punct
17	CD	appos
,	,	punct
86	CD	nummod
S.Ct	NNP	subtok
.	.	npadvmod
684	CD	nummod
,	,	punct
15	CD	nummod
l.ed.2d	NN	nmod
545	CD	nummod
(	-LRB-	punct
1966	CD	appos
)	-RRB-	punct
.	.	punct
-PRON-	PRP	nsubj
review	VBP	ccomp
the	DT	det
underlie	VBG	amod
finding	NNS	dobj
of	IN	prep
fact	NN	pobj
for	IN	prep
clear	JJ	amod
error	NN	pobj
,	,	punct
and	CC	cc
-PRON-	PRP	nsubj
review	VBP	conj
de	FW	nmod
novo	NN	dobj
the	DT	det
court	NN	poss
's	POS	case
ultimate	JJ	amod
legal	JJ	amod
conclusion	NN	dobj
of	IN	prep
whether	IN	mark
the	DT	det
claim	VBN	amod
invention	NN	nsubj
would	MD	aux
have	VB	aux
be	VBN	pcomp
obvious	JJ	acomp
.	.	punct
Novo	NNP	nmod
Nordisk	NNP	nmod
A	NNP	nmod
/	SYM	punct
S	NNP	appos
v.	CC	prep
Caraco	NNP	compound
Pharm.	NNP	subtok
Labs.	NNP	dobj
,	,	punct
Ltd.	NNP	amod
,	,	punct
719	CD	nummod
f.3d	CD	appos
1346	CD	appos
,	,	punct
1354	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2013	LS	appos
)	-RRB-	punct
.	.	punct
underlie	VBG	amod
factual	JJ	amod
inquiry	NNS	nsubj
include	VBP	ccomp
(	-LRB-	punct
i	LS	dobj
)	-RRB-	punct
the	DT	det
scope	NN	conj
and	CC	cc
content	NN	conj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
;	:	punct
(	-LRB-	punct
ii	LS	appos
)	-RRB-	punct
the	DT	det
difference	NNS	appos
between	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
and	CC	cc
the	DT	det
claim	NNS	conj
at	IN	prep
issue	NN	pobj
;	,	punct
(	-LRB-	punct
iii	LS	appos
)	-RRB-	punct
the	DT	det
level	NN	appos
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
field	NN	pobj
of	IN	prep
the	DT	det
invention	NN	pobj
;	:	punct
and	CC	cc
(	-LRB-	punct
iv	LS	nmod
)	-RRB-	punct
relevant	JJ	amod
secondary	JJ	amod
consideration	NNS	conj
.	.	punct
KSR	NNP	subtok
Int'l	NNP	subtok
Co.	NNP	punct
v.	IN	prep
Teleflex	NNP	nmod
,	,	punct
Inc.	NNP	conj
,	,	punct
550	CD	nummod
U.S.	NNP	appos
398	CD	nummod
,	,	punct
406	CD	appos
,	,	punct
127	CD	nummod
S.Ct	NNP	subtok
.	.	punct
1727	CD	npadvmod
,	,	punct
167	CD	nummod
l.ed.2d	NN	npadvmod
705	CD	nummod
(	-LRB-	punct
2007	CD	npadvmod
)	-RRB-	punct
;	:	punct
Graham	NNP	appos
,	,	punct
383	CD	nummod
U.S.	NNP	appos
at	IN	prep
17	CD	pobj
-	SYM	punct
18	CD	prep
,	,	punct
86	CD	nummod
S.Ct	NNP	subtok
.	.	punct
684	CD	nummod
.	.	punct

 	_SP	
I.	NNP	compound
Invalidity	NNP	nsubj
of	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
ABUK	NNP	compound
Patents	NNPS	pobj

  	_SP	
Purdue	NNP	pobj
challenge	VBZ	conj
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
conclusion	NN	dobj
that	IN	mark
the	DT	det
assert	VBN	amod
claim	NNS	nsubj
of	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
patent	NNS	pobj
be	VBP	acl
invalid	JJ	acomp
as	RB	prep
obvious	JJ	amod
.	.	punct
Those	DT	det
claim	NNS	nsubj
recite	VBP	conj
an	DT	det
oxycodone	NN	compound
API	NNP	compound
product	NN	dobj
with	IN	prep
low	JJ	amod
ABUK	NNP	pobj
levels.2	.	dep
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ccomp
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	nsubj
teach	VBD	ccomp
that	IN	dobj
oxidation	NN	pobj
of	IN	prep
thebaine	NN	pobj
produce	VBD	acl
14-hydroxy	JJ	dobj
and	CC	cc
that	IN	mark
-PRON-	PRP	nsubjpass
be	VBD	auxpass
well	RB	advmod
know	VBN	acl
in	IN	prep
the	DT	det
art	NN	pobj
that	WDT	mark
14-hydroxy	JJ	nsubjpass
could	MD	aux
be	VB	auxpass
remove	VBN	acl
use	VBG	advcl
hydrogenation	NN	dobj
.	.	punct
District	NNP	compound
Court	NNP	compound
Decision	NNP	dobj
,	,	punct
 	_SP	
994	CD	nummod
f.supp.2d	NN	appos
at	IN	prep
395	CD	pobj
-	SYM	punct
96	CD	prep
.	.	punct
the	DT	det
court	NN	nsubj
further	RB	advmod
determine	VBD	conj
that	IN	mark
the	DT	det
discovery	NN	nsubj
of	IN	prep
8�\	NN	pobj
be	VBD	ccomp
not	RB	neg
necessary	JJ	acomp
to	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
:	:	punct
a	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
recognize	VB	acl
that	DT	det
hydrogenation	NN	nsubjpass
could	MD	aux
be	VB	auxpass
use	VBN	ccomp
to	TO	aux
remove	VB	xcomp
the	DT	det
remain	VBG	amod
14-hydroxy	JJ	dobj
,	,	punct
regardless	RB	advmod
of	IN	prep
the	DT	det
source	NN	pobj
of	IN	prep
the	DT	det
14-hydroxy	JJ	pobj
.	.	punct
Idaho	NNS	dobj
at	IN	prep
405	CD	pobj
-	SYM	punct
06	CD	prep
.	.	punct
moreover	RB	advmod
,	,	punct
the	DT	det
court	NN	nsubj
conclude	VBD	conj
that	IN	mark
the	DT	det
claim	NN	nsubj
limitation	NN	ccomp
require	VBG	xcomp
that	IN	mark
the	DT	det
remain	VBG	amod
14-hydroxy	JJ	nsubj
be	VBZ	auxpass
at	IN	advmod
least	JJS	advmod
in	IN	prep
part	NN	pobj
"	''	punct
derive	VBN	ccomp
from	IN	prep
8�\	NNP	pobj
[	-LRB-	punct
]	-RRB-	punct
"	``	punct
be	VBZ	ccomp
a	DT	det
product	NN	nmod
-	HYPH	punct
by	IN	prep
-	HYPH	punct
process	NN	pobj
limitation	NN	attr
and	CC	cc
thus	RB	advmod
immaterial	JJ	conj
in	IN	prep
the	DT	det
obviousness	JJ	amod
determination	NN	pobj
.	.	punct
Idaho	NNS	dep
at	IN	prep
405	CD	pobj
.	.	punct
finally	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	advcl
that	IN	mark
the	DT	det
secondary	JJ	amod
consideration	NNS	nsubj
do	VBD	aux
not	RB	neg
demonstrate	VB	ccomp
nonobviousness	NN	dobj
.	.	punct
Idaho	NNS	conj
at	IN	prep
407	CD	pobj
.	.	punct
Purdue	NNP	nsubj
allege	VBZ	cc
clear	JJ	amod
error	NN	attr
in	IN	prep
a	DT	det
number	NN	pobj
of	IN	prep
the	DT	det
court	NN	poss
's	POS	case
finding	NNS	pobj
,	,	punct
but	CC	cc
none	NN	nsubj
of	IN	prep
-PRON-	PRP$	poss
argument	NNS	pobj
be	VBP	conj
meritorious	JJ	acomp
.	.	punct

 	_SP	
A.	NNP	compound
Discovery	NNP	cc
of	IN	prep
8�\	NNP	pobj

 	_SP	
First	NNP	advmod
,	,	punct
Purdue	NNP	nsubj
contend	VBZ	conj
that	IN	mark
the	DT	det
court	NN	nsubj
fail	VBD	ccomp
to	TO	aux
properly	RB	advmod
credit	VB	xcomp
the	DT	det
discovery	NN	dobj
of	IN	prep
8�\	NN	pobj
as	IN	prep
the	DT	det
core	NN	pobj
of	IN	prep
the	DT	det
claim	VBN	amod
invention	NNS	pobj
.	.	punct
-PRON-	PRP	nsubj
rely	VBZ	conj
heavily	RB	advmod
on	IN	prep
Eibel	NNP	compound
Process	NNP	compound
Co.	NNP	pobj
v.	CC	prep
Minnesota	NNP	pobj
&	CC	cc
Ontario	NNP	compound
Paper	NNP	compound
Co.	NNP	conj
,	,	punct
261	CD	nummod
U.S.	NNP	nmod
45	CD	nummod
,	,	punct
68	CD	nummod
,	,	punct
43	CD	nummod
s.ct	NN	subtok
.	.	npadvmod
322	CD	nummod
,	,	punct
67	CD	nummod
L.Ed	NNS	subtok
.	.	punct
523	CD	nummod
(	-LRB-	punct
1923	CD	appos
)	-RRB-	punct
,	,	punct
for	IN	prep
the	DT	det
proposition	NN	pobj
that	IN	mark
"	``	punct
where	WRB	advmod
an	DT	det
inventor	NN	nsubj
discover	VBZ	acl
a	DT	det
non	JJ	subtok
-	JJ	subtok
obvious	JJ	amod
source	NN	dobj
of	IN	prep
a	DT	det
problem	NN	pobj
and	CC	cc
then	RB	advmod
apply	VBZ	conj
a	DT	det
remedy	NN	dobj
in	IN	prep
response	NN	pobj
,	,	punct
the	DT	det
invention	NN	nsubj
be	VBZ	conj
nonobvious	JJ	acomp
and	CC	cc
worthy	JJ	conj
of	IN	prep
a	DT	det
patent	NN	pobj
-	:	punct
even	RB	advmod
if	IN	mark
the	DT	det
remedy	NN	nsubj
,	,	punct
stand	VBG	acl
alone	RB	advmod
,	,	punct
would	MD	aux
generally	RB	advmod
appear	VB	advcl
to	TO	aux
be	VB	auxpass
know	VBN	xcomp
in	IN	prep
the	DT	det
art	NN	pobj
"	''	punct
.	.	punct
Purdue	NNP	compound
Br	NNP	subtok
.	.	punct
40	CD	nummod
.	.	punct
In	IN	prep
Eibel	NNP	compound
Process	NNP	pobj
,	,	punct
the	DT	det
invention	NN	nsubj
be	VBD	ccomp
a	DT	det
machine	NN	attr
that	WDT	nsubj
could	MD	aux
make	VB	relcl
quality	NN	compound
paper	NN	dobj
at	IN	prep
high	JJ	amod
speed	NNS	pobj
.	.	punct
261	CD	nummod
U.S.	NNP	npadvmod
at	IN	prep
54	CD	pobj
,	,	punct
43	CD	nummod
s.ct	NN	subtok
.	.	appos
322	CD	nummod
.	.	punct
At	IN	prep
the	DT	det
time	NN	pobj
,	,	punct
paper	NN	npadvmod
-	HYPH	punct
make	VBG	amod
machine	NNS	nsubj
could	MD	aux
not	RB	neg
operate	VB	advcl
at	IN	prep
high	JJ	amod
speed	NNS	pobj
without	IN	prep
produce	VBG	pcomp
wrinkled	JJ	amod
paper	NN	dobj
.	.	punct
Idaho	NNP	compound
Eibel	NNP	nsubj
discover	VBD	conj
that	IN	mark
the	DT	det
unequal	JJ	amod
speed	NNS	nsubj
of	IN	prep
paper	NN	compound
stock	NN	pobj
and	CC	cc
a	DT	det
wire	NN	conj
in	IN	prep
the	DT	det
machine	NN	pobj
produce	VBD	ccomp
the	DT	det
wrinkled	JJ	amod
paper	NN	dobj
.	.	punct
thus	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
make	VBD	ccomp
a	DT	det
minor	JJ	amod
modification	NN	dobj
in	IN	prep
the	DT	det
exist	VBG	amod
paper	NN	npadvmod
-	HYPH	punct
make	VBG	amod
machine	NNS	pobj
:	:	punct
-PRON-	PRP	nsubj
increase	VBD	ccomp
the	DT	det
pitch	NN	dobj
(	-LRB-	punct
angle	NN	appos
)	-RRB-	punct
of	IN	prep
the	DT	det
wire	NN	pobj
so	IN	mark
that	IN	mark
,	,	punct
through	IN	prep
gravity	NN	pobj
,	,	punct
the	DT	det
paper	NN	compound
stock	NN	nsubj
would	MD	aux
travel	VB	advcl
at	IN	prep
substantially	RB	advmod
the	DT	det
same	JJ	amod
speed	NN	pobj
as	IN	prep
the	DT	det
wire	NN	pobj
,	,	punct
and	CC	cc
the	DT	det
paper	NN	nsubj
would	MD	aux
not	RB	neg
wrinkle	VB	conj
.	.	punct
Idaho	NNS	dep
at	IN	prep
57	CD	nummod
-	SYM	punct
58	CD	prep
,	,	punct
64	CD	appos
-	SYM	punct
65	CD	prep
,	,	punct
43	CD	nummod
s.ct	NN	subtok
.	.	pobj
322	CD	nummod
.	.	punct
the	DT	det
Supreme	NNP	compound
Court	NNP	nsubj
uphold	VBD	advcl
the	DT	det
validity	NN	dobj
of	IN	prep
Eibel	NNP	poss
's	POS	case
patent	NN	pobj
,	,	punct
reason	VBG	advcl
that	IN	mark
the	DT	det
discovery	NN	nsubj
of	IN	prep
the	DT	det
problem	NN	npadvmod
-	HYPH	punct
unequal	JJ	amod
speed	NNS	pobj
of	IN	prep
paper	NN	compound
stock	NN	pobj
and	CC	cc
the	DT	det
wire	NN	conj
-	,	punct
be	VBD	ccomp
nonobvious	JJ	acomp
,	,	punct
and	CC	cc
thus	RB	advmod
the	DT	det
solution	NN	nsubj
be	VBD	conj
as	RB	advmod
well	RB	advmod
.	.	punct
Idaho	NNS	dobj
at	IN	prep
68	CD	nummod
,	,	punct
43	CD	nummod
s.ct	NN	subtok
.	.	pobj
322	CD	nummod
.	.	punct
Purdue	NNP	nsubj
contend	VBZ	advcl
that	IN	mark
,	,	punct
similarly	RB	advmod
here	RB	advmod
,	,	punct
the	DT	det
discovery	NN	nsubj
of	IN	prep
the	DT	det
source	NN	pobj
of	IN	prep
14-hydroxy	JJ	pobj
be	VBD	ccomp
not	RB	neg
obvious	JJ	acomp
,	,	punct
so	RB	cc
the	DT	det
solution	NN	nsubj
of	IN	prep
hydrogenate	VBG	pcomp
the	DT	det
oxycodone	NN	compound
salt	NN	dobj
must	MD	aux
also	RB	advmod
be	VB	conj
nonobvious	JJ	acomp
.	.	punct

 	_SP	
Purdue	NNP	poss
's	POS	case
reliance	NN	nsubjpass
on	IN	prep
Eibel	NNP	compound
Process	NNP	pobj
be	VBZ	auxpass
misplace	VBN	conj
.	.	punct
even	RB	advmod
if	IN	mark
determine	VBG	csubj
the	DT	det
source	NN	dobj
of	IN	prep
14-hydroxy	JJ	pobj
in	IN	prep
the	DT	det
end	NN	compound
product	NN	pobj
be	VBD	advcl
not	RB	neg
obvious	JJ	acomp
,	,	punct
that	DT	det
problem	NN	nsubj
do	VBD	aux
not	RB	neg
need	VB	ccomp
to	TO	aux
be	VB	auxpass
solve	VBN	xcomp
to	TO	aux
arrive	VB	xcomp
at	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
;	:	punct
thus	RB	advmod
,	,	punct
Eibel	NNP	compound
Process	NNP	nsubj
do	VBZ	aux
not	RB	neg
apply	VB	ccomp
.	.	punct
As	IN	mark
discuss	VBN	advcl
above	RB	advmod
,	,	punct
the	DT	det
claim	VBN	amod
invention	NN	nsubj
in	IN	prep
Eibel	NNP	compound
Process	NNP	pobj
be	VBD	advcl
a	DT	det
machine	NN	attr
that	WDT	nsubj
remedie	VBD	relcl
the	DT	det
problem	NN	dobj
of	IN	prep
wrinkled	JJ	amod
paper	NN	pobj
at	IN	prep
high	JJ	amod
-	HYPH	punct
speed	NN	compound
printing	NN	pobj
.	.	punct
but	CC	cc
,	,	punct
here	RB	advmod
,	,	punct
Purdue	NNP	nsubj
do	VBD	aux
not	RB	neg
claim	VB	conj
the	DT	det
remedy	NN	dobj
of	IN	prep
the	DT	det
problem	NN	pobj
of	IN	prep
remain	VBG	pcomp
14-hydroxy	JJ	dobj
in	IN	prep
the	DT	det
oxycodone	NN	pobj
api	NN	npadvmod
-	HYPH	punct
perform	VBG	advcl
a	DT	det
second	JJ	amod
hydrogenation	NN	compound
step	NN	dobj
.	.	punct
instead	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
claim	VBD	ccomp
the	DT	det
end	NN	compound
product	NN	dobj
-	:	punct
an	DT	det
oxycodone	NN	compound
api	NN	appos
with	IN	prep
low	JJ	amod
ABUK	NNP	compound
level	NNS	pobj
.	.	punct
and	CC	cc
,	,	punct
as	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	advcl
,	,	punct
identification	NN	nsubj
of	IN	prep
the	DT	det
source	NN	pobj
of	IN	prep
the	DT	det
remain	VBG	amod
14-hydroxy	JJ	pobj
as	IN	prep
be	VBG	pcomp
8�\	JJ	acomp
have	VBD	conj
no	DT	det
effect	NN	dobj
on	IN	prep
the	DT	det
structure	NN	pobj
or	CC	cc
nature	NN	conj
of	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	compound
product	NN	pobj
.	.	punct
Because	IN	mark
"	``	punct
one	CD	nummod
molecule	NN	nsubj
of	IN	prep
14-hydroxy	JJ	pobj
be	VBZ	ccomp
the	DT	det
same	JJ	attr
as	IN	prep
the	DT	det
next	JJ	pobj
,	,	punct
whether	IN	mark
derive	VBN	advcl
from	IN	prep
8�\	JJ	pobj
or	CC	cc
8�]	NN	conj
,	,	punct
"	''	punct
knowledge	NN	nsubj
of	IN	prep
8�\	NN	pobj
"	''	punct
do	VBD	aux
not	RB	neg
make	VB	conj
hydrogenation	NN	nsubj
more	RBR	advmod
or	CC	cc
less	RBR	conj
effective	JJ	ccomp
as	IN	prep
a	DT	det
technique	NN	pobj
for	IN	prep
convert	VBG	pcomp
14-hydroxy	JJ	punct
to	IN	aux
oxycodone	NN	dobj
"	''	punct
.	.	punct
District	NNP	compound
Court	NNP	compound
Decision	NNP	dobj
,	,	punct
994	CD	nummod
f.supp.2d	NN	appos
at	IN	prep
405	CD	pobj
.	.	punct

 	_SP	
Purdue	NNP	nsubj
also	RB	advmod
argue	VBZ	ccomp
that	IN	mark
,	,	punct
without	IN	prep
know	VBG	pcomp
that	IN	mark
the	DT	det
14-hydroxy	JJ	nsubjpass
be	VBD	auxpass
derive	VBN	ccomp
from	IN	prep
8�\	NN	pobj
,	,	punct
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
not	RB	neg
know	VB	ccomp
when	WRB	advmod
to	TO	aux
conduct	VB	xcomp
the	DT	det
hydrogenation	NN	compound
step	NN	dobj
or	CC	cc
under	IN	conj
what	WDT	det
condition	NNS	pcomp
to	TO	aux
run	VB	acl
the	DT	det
hydrogenation	NN	dobj
to	TO	aux
create	VB	acl
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	dobj
.	.	punct
Purdue	NNP	nsubj
note	VBZ	ccomp
that	IN	mark
the	DT	det
prior	JJ	amod
art	NN	compound
reference	NNS	nsubjpass
be	VBD	auxpass
direct	VBN	ccomp
to	IN	prep
lower	VBG	pcomp
14-hydroxy	JJ	nummod
level	NNS	dobj
in	IN	prep
the	DT	det
oxycodone	NN	nmod
free	JJ	amod
base	NN	pobj
,	,	punct
not	RB	neg
the	DT	det
api	NN	appos
or	CC	cc
salt	NN	conj
.	.	punct
For	IN	prep
example	NN	pobj
,	,	punct
U.S.	NNP	compound
patent	NN	compound
No.	SYM	nsubj
6,177,567	CD	nummod
(	-LRB-	punct
"	``	punct
Chiu	NNP	compound
reference	NN	appos
"	''	punct
)	-RRB-	punct
disclose	VBD	ccomp
a	DT	det
method	NN	dobj
for	IN	prep
prepare	VBG	pcomp
low	JJ	amod
-	HYPH	punct
abuk	NN	nmod
free	JJ	amod
base	NN	dobj
,	,	punct
but	CC	cc
-PRON-	PRP	nsubj
do	VBD	aux
not	RB	neg
teach	VB	conj
how	WRB	advmod
to	TO	aux
convert	VB	xcomp
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	nmod
free	JJ	amod
base	NN	dobj
into	IN	prep
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
salt	NN	pobj
.	.	punct
In	IN	prep
fact	NN	pobj
,	,	punct
as	IN	mark
Purdue	NNP	nsubj
and	CC	cc
the	DT	det
district	NN	compound
court	NN	conj
note	VBD	advcl
,	,	punct
Chiu	NNP	nsubj
complete	VBD	ccomp
-PRON-	PRP$	poss
method	NN	dobj
by	IN	prep
add	VBG	pcomp
acetic	JJ	amod
acid	NN	dobj
to	IN	prep
the	DT	det
free	JJ	amod
base	NN	pobj
.	.	punct
In	IN	prep
so	RB	advmod
do	VBG	pcomp
,	,	punct
Chiu	NNP	nsubj
likely	RB	advmod
convert	VBD	ccomp
the	DT	det
latent	NN	compound
8�\	NN	dobj
into	IN	prep
14-hydroxy	JJ	pobj
in	IN	prep
the	DT	det
final	JJ	amod
product	NN	pobj
because	IN	mark
8�\	JJ	amod
react	VBZ	advcl
with	IN	prep
the	DT	det
acid	NN	pobj
to	TO	aux
form	VB	acl
14-hydroxy	JJ	dobj
.	.	punct
but	CC	cc
,	,	punct
again	RB	advmod
,	,	punct
Purdue	NNP	nsubj
claim	VBD	ccomp
the	DT	det
end	NN	compound
product	NN	dobj
;	:	punct
-PRON-	PRP	nsubj
do	VBD	aux
not	RB	neg
claim	VB	ROOT
a	DT	det
particular	JJ	amod
method	NN	dobj
for	IN	prep
create	VBG	pcomp
that	DT	det
product	NN	dobj
,	,	punct
such	JJ	amod
as	IN	prep
the	DT	det
use	NN	pobj
of	IN	prep
hydrogenation	NN	pobj
after	IN	prep
the	DT	det
salting	NN	compound
step	NN	pobj
.	.	punct
In	IN	prep
fact	NN	pobj
,	,	punct
Teva	NNP	poss
's	POS	case
generic	JJ	amod
product	NN	nsubj
would	MD	aux
not	RB	neg
infringe	VB	advcl
if	IN	mark
that	DT	nsubj
be	VBD	ccomp
the	DT	det
case	NN	attr
because	IN	mark
the	DT	det
Teva	NNP	compound
product	NN	nsubjpass
be	VBZ	auxpass
not	RB	neg
make	VBN	advcl
by	IN	agent
hydrogenate	VBG	pcomp
the	DT	det
salt	NN	dobj
-	:	punct
instead	RB	advmod
the	DT	det
free	JJ	amod
base	NN	nsubjpass
be	VBZ	auxpass
purify	VBN	conj
through	IN	prep
two	CD	nummod
hydrogenation	NN	compound
cycle	NNS	pobj
and	CC	cc
then	RB	advmod
be	VBZ	auxpass
treat	VBN	conj
with	IN	prep
acid	NN	pobj
to	TO	aux
create	VB	advcl
the	DT	det
oxycodone	NN	compound
salt	NN	dobj
.	.	punct
similarly	RB	advmod
,	,	punct
nothing	NN	nsubj
in	IN	prep
the	DT	det
asserted	JJ	amod
patent	NNS	pobj
indicate	VBZ	advcl
that	IN	mark
the	DT	det
hydrogenation	NN	compound
process	NN	nsubjpass
to	TO	aux
remove	VB	relcl
14-hydroxy	JJ	dep
derive	VBN	acl
from	IN	prep
8�\	NN	pobj
must	MD	aux
be	VB	auxpass
conduct	VBN	ccomp
under	IN	prep
different	JJ	amod
condition	NNS	pobj
from	IN	prep
the	DT	det
process	NN	pobj
use	VBN	acl
to	TO	aux
remove	VB	xcomp
14-hydroxy	JJ	dobj
that	WDT	nsubjpass
be	VBZ	auxpass
derive	VBN	relcl
from	IN	prep
8�].	CD	pobj
the	DT	det
issue	NN	nsubj
again	RB	advmod
come	VBZ	ccomp
down	RP	prt
to	IN	prep
whether	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
be	VB	pcomp
obvious	JJ	acomp
to	IN	prep
a	DT	det
person	NN	pobj
have	VBG	acl
ordinary	JJ	amod
skill	NN	dobj
in	IN	prep
the	DT	det
art	NN	pobj
to	TO	aux
use	VB	advcl
hydrogenation	NN	dobj
to	TO	aux
remove	VB	xcomp
the	DT	det
excess	JJ	amod
14-hydroxy	JJ	dobj
in	IN	prep
the	DT	det
oxycodone	NN	compound
api	NN	pobj
.	.	punct
one	CD	nsubj
nee	MD	nsubj
not	RB	neg
know	VB	conj
that	IN	mark
the	DT	det
14-hydroxy	JJ	nsubjpass
be	VBD	auxpass
derive	VBN	ccomp
from	IN	prep
8�\	JJ	pobj
as	IN	mark
oppose	VBN	advcl
to	IN	prep
8�]	NN	pobj
to	TO	aux
answer	VB	advcl
that	DT	det
question	NN	dobj
.	.	punct

 	_SP	
B.	NNP	nsubj
"	''	punct
derive	VBN	advcl
from	IN	prep
8�\	NNP	pobj
[	-LRB-	punct
]	-RRB-	punct

"	``	punct
Limitation	NNP	nmod

 	_SP	
Purdue	NNP	nsubj
next	RB	advmod
argue	VBZ	ROOT
that	IN	dobj
,	,	punct
because	IN	mark
the	DT	det
assert	VBN	amod
claim	NNS	nsubj
require	VBP	advcl
that	IN	mark
the	DT	det
remain	VBG	amod
14-hydroxy	JJ	nsubjpass
in	IN	prep
the	DT	det
oxycodone	NN	compound
API	NNP	pobj
be	VBZ	auxpass
derive	VBN	ccomp
from	IN	prep
8�\	JJ	pobj
and	CC	cc
because	IN	mark
8�\	NN	nsubjpass
be	VBD	auxpass
not	RB	neg
previously	RB	advmod
know	VBN	advcl
in	IN	prep
the	DT	det
art	NN	pobj
as	IN	prep
be	VBG	pcomp
the	DT	det
source	NN	attr
of	IN	prep
14-hydroxy	JJ	punct
,	,	punct
the	DT	det
claim	NNS	nsubj
must	MD	aux
be	VB	conj
nonobvious	JJ	acomp
.	.	punct
indeed	RB	advmod
,	,	punct
Purdue	NNP	nsubj
point	VBZ	ccomp
out	RP	prt
that	IN	mark
the	DT	det
reason	NN	appos
-PRON-	PRP	nsubj
add	VBD	relcl
that	IN	mark
limitation	NN	nsubj
be	VBD	ccomp
because	IN	prep
of	IN	pcomp
-PRON-	PRP$	poss
decision	NN	pobj
in	IN	prep
Chapman	NNP	pobj
where	WRB	advmod
-PRON-	PRP	nsubj
say	VBD	relcl
the	DT	det
claim	NNS	nsubj
be	VBD	ccomp
obvious	JJ	acomp
because	IN	mark
the	DT	det
claim	NNS	nsubj
do	VBD	aux
not	RB	neg
differentiate	VB	advcl
between	IN	prep
the	DT	det
8�\	NN	pobj
and	CC	cc
8�].	CD	compound
315	CD	nummod
Fed	NNP	conj
.	.	punct
Appx	NNP	attr
.	.	punct
at	IN	prep
297	CD	pobj
.	.	punct
the	DT	det
district	NN	compound
court	NN	nsubj
reject	VBD	ccomp
that	DT	det
argument	NN	dobj
because	IN	mark
-PRON-	PRP	nsubj
find	VBD	advcl
that	IN	dobj
the	DT	det
"	``	punct
derive	VBN	pobj
from	IN	prep
8�\	NNP	pobj
[	-LRB-	punct
]	-RRB-	punct
"	``	punct
limitation	NN	nsubj
be	VBD	advcl
a	DT	det
process	NN	compound
limitation	NN	attr
and	CC	cc
thus	RB	advmod
immaterial	JJ	conj
to	IN	prep
the	DT	det
obviousness	JJ	amod
analysis	NN	pobj
.	.	punct

 	_SP	
Purdue	NNP	nsubj
say	VBZ	parataxis
,	,	punct
first	RB	advmod
,	,	punct
the	DT	det
limitation	NN	nsubj
be	VBZ	ccomp
not	RB	neg
a	DT	det
process	NN	compound
limitation	NN	attr
,	,	punct
and	CC	cc
,	,	punct
second	JJ	conj
,	,	punct
even	RB	advmod
if	IN	mark
-PRON-	PRP	nsubj
be	VBZ	advcl
,	,	punct
-PRON-	PRP	nsubjpass
should	MD	aux
not	RB	neg
be	VB	auxpass
wholly	RB	advmod
disregard	VBN	ccomp
.	.	punct
again	RB	advmod
,	,	punct
Purdue	NNP	poss
's	POS	case
argument	NNS	nsubj
fail	VBP	ccomp
.	.	punct

 	_SP	
the	DT	det
relevant	JJ	amod
claim	NN	compound
language	NN	nsubj
provide	VBZ	ccomp
:	:	punct

 	_SP	
an	DT	det
oral	JJ	amod
dosage	NN	compound
form	NN	nsubj
comprising	NN	ccomp
...	:	punct
oxycodone	NN	nsubj
hydrochloride	VBP	dep
active	JJ	amod
pharmaceutical	NN	amod
ingredient	NN	dobj
have	VBG	acl
less	JJR	amod
than	IN	quantmod
25	CD	nummod
ppm	NNS	dobj
14-hydroxy	JJ	punct
[	-LRB-	punct
]	-RRB-	punct
,	,	punct
wherein	WRB	advmod
at	IN	advmod
least	JJS	advmod
a	DT	det
portion	NN	appos
of	IN	prep
the	DT	det
14-hydroxy	JJ	pobj

[	-LRB-	punct
]	-RRB-	punct
be	VBZ	auxpass
derive	VBN	ROOT
from	IN	prep
8	CD	nummod
�\	NNS	pobj
[	-LRB-	punct
]	-RRB-	punct
during	IN	prep
conversion	NN	pobj
of	IN	prep
oxycodone	NN	nmod
free	JJ	amod
base	NN	pobj
to	IN	aux
oxycodone	NN	acl
hydrochloride[.	NNPS	npadvmod
]	-RRB-	punct

 	_SP	
see	VBP	conj
,	,	punct
e.g.	RB	advmod
,	,	punct
��799	,	compound
patent	NN	compound
col.	NN	npadvmod
to	TO	prep
col.	VB	nummod

(	-LRB-	punct
emphasis	NN	nsubj
add	VBN	ccomp
)	-RRB-	punct
.	.	punct
-PRON-	PRP	nsubj
agree	VBP	ccomp
with	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
that	IN	mark
"	``	punct
derive	VBN	ccomp
from	IN	prep
8�\	NNP	pobj
[	-LRB-	punct
]	-RRB-	punct
"	``	punct
do	VBZ	aux
not	RB	neg
describe	VB	ccomp
the	DT	det
structure	NN	dobj
of	IN	prep
14-hydroxy	JJ	pobj
and	CC	cc
thus	RB	advmod
be	VBZ	conj
a	DT	det
process	NN	compound
limitation	NN	attr
.	.	punct
the	DT	det
patent	NN	compound
specification	NN	nsubj
describe	VBZ	ccomp
method	NNS	dobj
for	IN	prep
detect	VBG	pcomp
and	CC	cc
remove	VBG	conj
14-hydroxy	JJ	dobj
without	IN	prep
regard	NN	pobj
to	IN	prep
the	DT	det
source	NN	pobj
.	.	punct
For	IN	prep
example	NN	pobj
,	,	punct
the	DT	det
write	VBN	amod
description	NN	nsubj
define	VBZ	ccomp
8,14-dihydroxy	CD	dobj
as	IN	prep
8�\	JJ	pobj
,	,	punct
8�]	NN	conj
,	,	punct
or	CC	cc
a	DT	det
mixture	NN	conj
of	IN	prep
the	DT	det
two	CD	pobj
and	CC	cc
do	VBZ	aux
not	RB	neg
indicate	VB	conj
any	DT	det
difference	NN	dobj
in	IN	prep
the	DT	det
result	VBG	amod
14-hydrodxy	JJ	nummod
depend	VBG	pobj
on	IN	prep
the	DT	det
particular	JJ	amod
isomer	NN	pobj
from	IN	prep
which	WDT	pobj
-PRON-	PRP	nsubjpass
be	VBZ	auxpass
derive	VBN	relcl
.	.	punct
more	RBR	advmod
specifically	RB	advmod
,	,	punct
there	EX	expl
be	VBZ	ROOT
no	DT	det
suggestion	NN	attr
in	IN	prep
the	DT	det
patent	NNS	pobj
that	WDT	mark
the	DT	det
hydrogenation	NN	compound
process	NN	nsubj
change	VBZ	nsubj
depend	VBG	acl
on	IN	prep
whether	IN	mark
the	DT	det
14-hydroxy	JJ	nsubjpass
be	VBZ	auxpass
create	VBN	pcomp
by	IN	agent
8�\	NN	pobj
or	CC	cc
8�].	CD	conj
indeed	RB	advmod
,	,	punct
even	RB	advmod
Purdue	NNP	poss
's	POS	case
expert	NN	nsubj
testify	VBD	acl
that	IN	mark
"	``	punct
the	DT	det
structure	NN	nsubj
of	IN	prep
the	DT	det
14-hydroxy	JJ	pobj
that	WDT	nsubjpass
be	VBZ	auxpass
generate	VBN	relcl
from	IN	prep
8�\	NNP	pobj
be	VBZ	ccomp
the	DT	det
same	JJ	amod
structure	NN	attr
that	WDT	nsubjpass
be	VBZ	auxpass
generate	VBN	relcl
from	IN	prep
8�].	CD	nummod
"	``	punct
J.A.	NNP	pobj
4428	CD	nummod
.	.	punct
Because	IN	mark
the	DT	det
source	NN	nsubj
of	IN	prep
the	DT	det
14-hydroxy	JJ	pobj
have	VBZ	advcl
no	DT	det
effect	NN	dobj
on	IN	prep
-PRON-	PRP$	poss
structure	NN	pobj
or	CC	cc
-PRON-	PRP$	poss
removal	NN	conj
through	IN	prep
hydrogenation	NN	pobj
,	,	punct
the	DT	det
limitation	NN	nsubj
that	WDT	mark
-PRON-	PRP	nsubjpass
be	VB	auxpass
"	``	punct
derive	VBN	acl
from	IN	prep
8�\	NNP	pobj
[	-LRB-	punct
]	-RRB-	punct
"	``	punct
can	MD	aux
not	RB	neg
be	VB	advcl
a	DT	det
structural	JJ	amod
limitation	NN	attr
.	.	punct

 	_SP	
-PRON-	PRP	nsubj
also	RB	advmod
conclude	VBP	advcl
that	IN	dobj
,	,	punct
because	IN	mark
"	``	punct
derive	VBN	advcl
from	IN	prep
8�\	NNP	pobj
[	-LRB-	punct
]	-RRB-	punct
"	``	punct
be	VBZ	ccomp
a	DT	det
process	NN	compound
limitation	NN	attr
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
err	VB	conj
in	IN	prep
disregard	VBG	pcomp
the	DT	det
limitation	NN	dobj
in	IN	prep
-PRON-	PRP$	poss
obviousness	JJ	amod
analysis	NN	pobj
.	.	punct
-PRON-	PRP	nsubj
have	VBP	aux
clearly	RB	advmod
state	VBN	ccomp
that	IN	mark
"	``	punct
'	``	punct
in	IN	prep
determine	VBG	pcomp
validity	NN	dobj
of	IN	prep
a	DT	det
product	NN	nmod
-	HYPH	punct
by	IN	prep
-	HYPH	punct
process	NN	pobj
claim	NN	pobj
,	,	punct
the	DT	det
focus	NN	nsubj
be	VBZ	ccomp
on	IN	prep
the	DT	det
product	NN	pobj
and	CC	cc
not	RB	neg
the	DT	det
process	NN	conj
of	IN	prep
make	VBG	pcomp
-PRON-	PRP	dobj
.	.	punct
'	''	punct

"	``	punct
Greenliant	NNP	compound
Sys	NNP	ROOT
.	NNP	punct
,	,	punct
Inc.	NNP	conj
v.	CC	prep
Xicor	NNP	compound
LLC	NNP	conj
,	,	punct
692	CD	nummod
f.3d	CD	appos
1261	CD	nummod
,	,	punct
1268	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2012	NNS	appos
)	-RRB-	punct
(	-LRB-	punct
quote	VBG	acl
Amgen	NNP	compound
Inc.	NNP	dobj
v.	CC	prep
F.	NNP	compound
Hoffman	NNP	compound
-	HYPH	punct
La	NNP	compound
Roche	NNP	compound
Ltd.	NNP	pobj
,	,	punct
580	CD	nummod
f.3d	CD	appos
1340	CD	nummod
,	,	punct
1369	CD	npadvmod
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.2009	LS	conj
)	-RRB-	punct
)	-RRB-	punct
.	.	punct
"	''	punct

that	DT	nsubj
be	VBZ	ccomp
because	IN	prep
of	IN	pcomp
the	DT	det
...	NFP	punct
longstanding	JJ	amod
rule	NN	pobj
that	IN	mark
an	DT	det
old	JJ	amod
product	NN	nsubj
be	VBZ	acl
not	RB	neg
patentable	JJ	acomp
even	RB	advmod
if	IN	mark
-PRON-	PRP	nsubjpass
be	VBZ	auxpass
make	VBN	advcl
by	IN	agent
a	DT	det
new	JJ	amod
process	NN	pobj
"	''	punct
.	.	punct
Idaho	NNP	cc
;	:	punct
see	VB	ROOT
also	RB	advmod
SmithKline	NNP	compound
Beecham	NNP	compound
Corp.	NNP	nsubj
v.	CC	prep
Apotex	NNP	compound
Corp.	NNP	pobj
,	,	punct
439	CD	nummod
f.3d	CD	conj
1312	CD	appos
,	,	punct
1317	CD	npadvmod

(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
cir.2006	ADD	ccomp
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
-PRON-	PRP	nsubjpass
have	VBZ	aux
long	RB	advmod
be	VBN	auxpass
establish	VBN	ccomp
that	IN	mark
one	PRP	nsubj
can	MD	aux
not	RB	neg
avoid	VB	ccomp
anticipation	NN	dobj
by	IN	prep
an	DT	det
early	JJR	amod
product	NN	compound
disclosure	NN	pobj
by	IN	prep
claim	VBG	pcomp
...	:	punct
the	DT	det
product	NN	dobj
as	IN	mark
produce	VBN	advcl
by	IN	agent
a	DT	det
particular	JJ	amod
process	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
;	.	punct
In	IN	prep
re	IN	pobj
Thorpe	NNP	pobj
,	,	punct
777	CD	nummod
f.2d	CD	nummod
695	CD	nummod
,	,	punct
697	CD	appos
(	-LRB-	punct
Fed	NNP	nmod
.	.	punct
Cir.1985	LS	ROOT
)	-RRB-	punct
(	-LRB-	punct
"	``	punct
If	IN	mark
the	DT	det
product	NN	nsubj
in	IN	prep
a	DT	det
product	NN	nmod
-	HYPH	punct
by	IN	prep
-	HYPH	punct
process	NN	pobj
claim	NN	pobj
be	VBZ	advcl
the	DT	det
same	JJ	attr
as	IN	prep
or	CC	cc
obvious	JJ	conj
from	IN	prep
a	DT	det
product	NN	pobj
of	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
the	DT	det
claim	NN	nsubj
be	VBZ	ccomp
unpatentable	JJ	acomp
even	RB	advmod
though	IN	mark
the	DT	det
prior	JJ	amod
product	NN	nsubjpass
be	VBD	auxpass
make	VBN	advcl
by	IN	agent
a	DT	det
different	JJ	amod
process	NN	pobj
"	''	punct
.	.	punct
)	-RRB-	punct
.	.	punct

 	_SP	
Purdue	NNP	nsubj
look	VBZ	relcl
to	IN	prep
the	DT	det
exception	NN	pobj
-PRON-	PRP	nsubj
carve	VBD	relcl
out	RP	prt
in	IN	prep
Amgen	NNP	pobj
:	:	punct
"	``	punct
if	IN	mark
the	DT	det
process	NN	nsubj
by	IN	prep
which	WDT	pobj
a	DT	det
product	NN	nsubjpass
be	VBZ	auxpass
make	VBN	relcl
impart	NNS	poss
'	POS	case
structural	JJ	amod
and	CC	cc
functional	JJ	conj
difference	NNS	nsubj
'	POS	case
distinguish	VBG	advcl
the	DT	det
claim	VBN	amod
product	NN	dobj
from	IN	prep
the	DT	det
prior	JJ	amod
art	NN	pobj
,	,	punct
then	RB	advmod
those	DT	det
difference	NNS	nsubj
'	''	case
be	VBP	ccomp
relevant	JJ	acomp
as	IN	prep
evidence	NN	pobj
of	IN	prep
no	DT	det
anticipation	NN	pobj
'	''	punct
although	IN	mark
-PRON-	PRP	nsubj
'	''	punct
be	VBP	advcl
not	RB	neg
explicitly	RB	advmod
part	NN	attr
of	IN	prep
the	DT	det
claim	NN	pobj
.	.	punct
'	''	punct

"	``	punct
Greenliant	NNP	advmod
,	,	punct
692	CD	nummod
f.3d	CD	appos
at	IN	prep
1268	CD	pobj
(	-LRB-	punct
quote	VBG	acl
Amgen	NNP	dobj
,	,	punct
580	CD	nummod
f.3d	CD	appos
at	IN	prep
1340	CD	pobj
)	-RRB-	punct
.	.	punct
As	IN	mark
previously	RB	advmod
discuss	VBN	advcl
,	,	punct
however	RB	advmod
,	,	punct
the	DT	det
fact	NN	appos
that	IN	mark
the	DT	det
14-hydroxy	JJ	nsubjpass
be	VBZ	auxpass
derive	VBN	acl
from	IN	prep
8�\	JJ	amod
impart	NNS	pobj
no	DT	det
structural	JJ	amod
or	CC	cc
functional	JJ	conj
difference	NNS	pobj
in	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
hydrocodone	NN	compound
api	NN	pobj
as	IN	mark
compare	VBN	prep
to	IN	prep
the	DT	det
prior	JJ	amod
art	NN	compound
product	NNS	pobj
.	.	punct
thus	RB	advmod
,	,	punct
the	DT	det
court	NN	nsubj
do	VBD	aux
not	RB	neg
err	VB	ccomp
in	IN	prep
disregard	VBG	pcomp
the	DT	det
process	NN	compound
limitation	NN	dobj
in	IN	prep
-PRON-	PRP$	poss
obviousness	JJ	amod
determination	NN	pobj
.	.	punct

 	_SP	
C.	NNP	compound
Secondary	NNP	compound
Considerations	NNPS	dobj

 	_SP	
Finally	NNP	advmod
,	,	punct
Purdue	NNP	nsubj
contend	VBZ	ccomp
that	IN	mark
the	DT	det
court	NN	nsubj
erroneously	RB	advmod
discount	VBD	ccomp
the	DT	det
secondary	JJ	amod
consideration	NNS	dobj
which	WDT	nsubj
-PRON-	PRP	nsubj
argue	VBZ	relcl
demonstrate	JJ	ccomp
nonobviousness	NN	dobj
.	.	punct
Purdue	NNP	nmod
first	JJ	amod
point	NNS	dobj
to	IN	prep
Rhodes	NNP	poss
's	POS	case
commercial	JJ	amod
success	NN	pobj
;	:	punct
-PRON-	PRP	nsubj
say	VBZ	ccomp
that	IN	mark
Rhodes	NNP	nsubj
become	VBD	ccomp
Purdue	NNP	poss
's	POS	case
oxycodone	NN	compound
api	NN	compound
supplier	NN	attr
by	IN	prep
market	VBG	pcomp
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
feature	NNS	dobj
of	IN	prep
-PRON-	PRP$	poss
product	NN	pobj
to	IN	prep
Purdue	NNP	pobj
,	,	punct
which	WDT	nsubj
result	VBD	relcl
in	IN	prep
almost	RB	advmod
$	$	quantmod
71	CD	compound
million	CD	pobj
in	IN	prep
sale	NNS	pobj
in	IN	prep
2010	CD	pobj
.	.	punct
As	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	advcl
,	,	punct
however	RB	advmod
,	,	punct
Rhodes	NNP	nsubj
be	VBD	ccomp
not	RB	neg
successful	JJ	acomp
at	IN	prep
market	VBG	pcomp
-PRON-	PRP$	poss
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	compound
API	NNP	dobj
to	IN	prep
any	DT	det
significant	JJ	amod
customer	NN	pobj
other	JJ	amod
than	IN	prep
Purdue	NNP	pobj
,	,	punct
which	WDT	nsubj
be	VBZ	relcl
-PRON-	PRP$	poss
corporate	JJ	amod
affiliate	NN	attr
.	.	punct
the	DT	det
district	NN	compound
court	NN	nsubj
further	RB	advmod
find	VBD	ccomp
that	IN	mark
Purdue	NNP	nsubj
invest	VBD	ccomp
in	IN	prep
Rhodes	NNP	pobj
not	RB	neg
because	IN	prep
of	IN	pcomp
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
feature	NNS	pobj
,	,	punct
but	CC	cc
because	IN	mark
-PRON-	PRP	nsubj
could	MD	aux
get	VB	conj
oxycodone	NN	compound
API	NNP	dobj
at	IN	prep
a	DT	det
low	JJR	amod
cost	NN	pobj
from	IN	prep
-PRON-	PRP$	poss
subsidiary	NN	pobj
than	IN	mark
-PRON-	PRP	nsubj
could	MD	advcl
from	IN	prep
an	DT	det
unaffiliated	JJ	amod
manufacturer	NN	pobj
during	IN	prep
time	NNS	pobj
of	IN	prep
high	JJ	amod
demand	NN	pobj
.	.	punct
Purdue	NNP	nsubj
do	VBZ	aux
not	RB	neg
persuasively	RB	advmod
rebut	VB	ccomp
these	DT	det
finding	NNS	dobj
on	IN	prep
appeal	NN	pobj
.	.	punct
thus	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
clearly	RB	advmod
err	VB	ccomp
in	IN	prep
conclude	VBG	pcomp
that	IN	mark
there	EX	expl
be	VBD	ccomp
no	DT	det
nexus	NN	attr
between	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
product	NN	pobj
of	IN	prep
the	DT	det
patent	NNS	pobj
and	CC	cc
the	DT	det
commercial	JJ	amod
success	NN	conj
of	IN	prep
Purdue	NNP	pobj
or	CC	cc
Rhodes	NNP	conj
.	.	punct

 	_SP	
Purdue	NNP	cc
next	RB	advmod
argue	VBZ	ccomp
that	IN	mark
the	DT	det
failure	NN	nsubjpass
of	IN	prep
other	NNS	pobj
be	VBZ	auxpass
show	VBN	ccomp
by	IN	agent
the	DT	det
experience	NN	pobj
of	IN	prep
Teva	NNP	poss
's	POS	case
oxycodone	NN	compound
api	NN	compound
supplier	NN	pobj
,	,	punct
Noramco	NNP	npadvmod
,	,	punct
Inc.	NNP	appos
(	-LRB-	punct
"	``	punct
Noramco	NNP	npadvmod
"	''	punct
)	-RRB-	punct
.	.	punct
Purdue	NNP	nsubj
claim	VBZ	ccomp
Noramco	NNP	nsubj
be	VBD	ccomp
unable	JJ	acomp
to	TO	aux
obtain	VB	xcomp
low	JJ	amod
ABUK	NNP	compound
level	NNS	dobj
until	IN	prep
2007	CD	pobj
,	,	punct
year	NNS	npadvmod
after	IN	mark
Purdue	NNP	nsubj
discover	VBD	advcl
8�\	NN	dobj
,	,	punct
and	CC	cc
only	RB	advmod
then	RB	conj
by	IN	prep
infringe	VBG	pcomp
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
patent	NNS	dobj
.	.	punct
but	CC	cc
,	,	punct
as	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	advcl
,	,	punct
there	EX	expl
be	VBZ	ccomp
no	DT	det
evidence	NN	attr
that	IN	mark
Noramco	NNP	nsubj
try	VBD	acl
but	CC	cc
fail	VBD	conj
to	TO	aux
create	VB	xcomp
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	compound
api	NN	dobj
.	.	punct
instead	RB	advmod
,	,	punct
the	DT	det
record	NN	nsubj
show	VBD	ccomp
that	IN	mark
Noramco	NNP	nsubj
and	CC	cc
the	DT	det
FDA	NNP	conj
agree	VBD	ccomp
to	IN	prep
a	DT	det
timetable	NN	pobj
for	IN	prep
produce	VBG	pcomp
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	compound
api	NN	dobj
,	,	punct
that	IN	mark
Noramco	NNP	nsubj
adhere	VBD	ccomp
to	IN	prep
that	DT	det
timetable	NN	pobj
,	,	punct
and	CC	cc
that	IN	mark
Noramco	NNP	nsubj
continue	VBD	conj
to	TO	aux
manufacture	VB	xcomp
the	DT	det
high	JJR	amod
ABUK	NNP	compound
product	NNS	dobj
during	IN	prep
that	DT	det
time	NN	pobj
.	.	punct
Purdue	NNP	nsubj
also	RB	advmod
argue	VBZ	ccomp
that	IN	mark
long	RB	advmod
-	HYPH	punct
feel	VBN	compound
need	NN	nsubjpass
be	VBD	auxpass
show	VBN	ccomp
because	IN	mark
,	,	punct
although	IN	mark
the	DT	det
FDA	NNP	nsubj
only	RB	advmod
make	VBD	advcl
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	compound
API	VBD	dative
a	DT	det
regulatory	JJ	amod
requirement	NN	ccomp
in	IN	prep
2003-less	CD	punct
than	IN	pobj
a	DT	det
year	NN	npadvmod
before	IN	mark
Purdue	NNP	nsubj
commercialize	VBD	advcl
-PRON-	PRP$	poss
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
product	NN	dobj
-	:	punct
the	DT	det
need	NN	nsubj
for	IN	prep
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
product	NNS	pobj
be	VBD	ccomp
present	JJ	acomp
long	RB	advmod
before	RB	advmod
.	.	punct
that	DT	nsubj
do	VBZ	aux
not	RB	neg
,	,	punct
however	RB	advmod
,	,	punct
change	VB	ccomp
the	DT	det
fact	NN	dobj
that	IN	mark
there	EX	expl
be	VBD	acl
no	DT	det
press	VBG	amod
need	NN	attr
for	IN	mark
company	NNS	nsubj
to	TO	aux
create	VB	advcl
a	DT	det
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
product	NN	dobj
before	IN	prep
the	DT	det
FDA	NNP	poss
's	POS	case
mandate	NN	pobj
,	,	punct
as	IN	mark
-PRON-	PRP	nsubj
be	VBD	advcl
able	JJ	acomp
to	TO	aux
continue	VB	xcomp
to	TO	aux
sell	VB	xcomp
-PRON-	PRP$	poss
high	JJR	amod
-	HYPH	punct
abuk	NN	compound
product	NNS	dobj
.	.	punct
thus	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
clearly	RB	advmod
err	VB	advcl
in	IN	prep
find	VBG	pcomp
that	IN	mark
Purdue	NNP	nsubj
fail	VBD	ccomp
to	TO	aux
prove	VB	xcomp
the	DT	det
failure	NN	dobj
of	IN	prep
other	NNS	pobj
or	CC	cc
long	RB	advmod
-	HYPH	punct
feel	VBN	nmod
but	CC	cc
unaddressed	JJ	amod
need	NN	conj
.	.	punct

 	_SP	
finally	RB	advmod
,	,	punct
Purdue	NNP	nsubj
point	VBZ	ccomp
to	IN	prep
the	DT	det
fact	NN	pobj
that	IN	mark
Noramco	NNP	nsubj
credit	VBD	acl
Purdue	NNP	dobj
and	CC	cc
Rhodes	NNP	conj
with	IN	prep
the	DT	det
discovery	NN	pobj
of	IN	prep
8�\	NN	pobj
and	CC	cc
contend	VBZ	conj
that	IN	mark
such	JJ	amod
recognition	NN	nsubj
show	VBZ	ccomp
praise	NN	dobj
from	IN	prep
competitor	NNS	pobj
.	.	punct
but	CC	cc
recognition	NN	nsubj
that	WDT	dobj
Rhodes	NNP	nsubj
discover	VBD	acl
that	IN	mark
8�\	NN	nsubj
be	VBZ	ccomp
a	DT	det
byproduct	NN	attr
of	IN	prep
thebaine	NN	compound
oxidation	NN	pobj
do	VBZ	aux
not	RB	neg
equal	VB	ccomp
praise	NN	dobj
for	IN	prep
the	DT	det
invention	NN	pobj
-	:	punct
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	compound
api	NN	appos
.	.	punct
Purdue	NNP	nsubj
also	RB	advmod
argue	VBZ	ccomp
that	IN	mark
industry	NN	compound
praise	NN	nsubjpass
be	VBZ	auxpass
show	VBN	ccomp
because	IN	mark
Noramco	NNP	nsubj
copy	VBD	advcl
-PRON-	PRP$	poss
process	NN	dobj
for	IN	prep
create	VBG	pcomp
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	dobj
,	,	punct
but	CC	cc
provide	VBZ	conj
no	DT	det
support	NN	dobj
whatsoever	RB	advmod
for	IN	prep
that	DT	det
argument	NN	pobj
.	.	punct
finally	RB	advmod
,	,	punct
Purdue	NNP	nsubj
contend	VBZ	ccomp
that	IN	mark
the	DT	det
court	NN	nsubj
wholly	RB	advmod
ignore	VBN	ccomp
evidence	NN	dobj
show	VBG	acl
that	IN	mark
Purdue	NNP	nsubj
and	CC	cc
Rhodes	NNP	conj
be	VBD	ccomp
surprised	JJ	acomp
over	IN	prep
-PRON-	PRP$	poss
discovery	NN	pobj
and	CC	cc
solution	NN	conj
.	.	punct
but	CC	cc
,	,	punct
again	RB	advmod
,	,	punct
there	EX	expl
be	VBD	ccomp
no	DT	det
surprise	NN	attr
as	IN	prep
to	IN	prep
the	DT	det
patented	JJ	amod
product	NN	pobj
.	.	punct
even	RB	advmod
if	IN	mark
-PRON-	PRP	nsubj
be	VBD	advcl
unexpected	JJ	acomp
that	IN	mark
thebaine	NN	compound
oxidation	NN	nsubj
would	MD	aux
create	VB	ccomp
8�\	JJ	dobj
,	,	punct
-PRON-	PRP	nsubj
be	VBD	advcl
not	RB	neg
surprising	JJ	acomp
that	IN	mark
,	,	punct
after	IN	prep
the	DT	det
FDA	NNP	compound
mandate	NN	pobj
,	,	punct
manufacturer	NNS	nsubj
would	MD	aux
create	VB	ccomp
a	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	compound
api	NN	dobj
or	CC	cc
that	IN	mark
-PRON-	PRP	nsubj
would	MD	aux
do	VB	conj
so	RB	advmod
use	VBG	advcl
the	DT	det
known	JJ	amod
technique	NN	dobj
of	IN	prep
hydrogenation	NN	pobj
.	.	punct

 	_SP	
-PRON-	PRP	nsubj
find	VBP	ccomp
Purdue	NNP	poss
's	POS	case
remain	VBG	amod
argument	NNS	nsubj
unpersuasive	JJ	ccomp
and	CC	cc
conclude	VBP	conj
that	IN	mark
the	DT	det
assert	VBN	amod
claim	NNS	nsubj
of	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
patent	NNS	pobj
be	VBP	ccomp
obvious	JJ	acomp
.	.	punct
-PRON-	PRP	nsubj
thus	RB	advmod
affirm	VBP	ccomp
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NN	dobj
of	IN	prep
invalidity	NN	pobj
as	IN	prep
to	IN	prep
those	DT	det
claim	NNS	pobj
.	.	punct

 	_SP	
II	NNP	cc
.	.	punct
invalidity	NN	nsubj
of	IN	prep
the	DT	det
��383	DT	compound
patent	NN	nmod

  	_SP	
Purdue	NNP	pobj
and	CC	cc
Grunenthal	NNP	conj
also	RB	advmod
challenge	VBP	ccomp
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
conclusion	NN	dobj
that	IN	mark
the	DT	det
assert	VBN	amod
claim	NNS	nsubj
of	IN	prep
the	DT	det
��383	DT	compound
patent	NN	pobj
be	VBP	acl
invalid	JJ	acomp
as	IN	mark
anticipate	VBN	advcl
,	,	punct
or	CC	cc
,	,	punct
in	IN	prep
the	DT	det
alternative	NN	pobj
,	,	punct
obvious.3	CD	cc
the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	conj
that	IN	mark
the	DT	det
assert	VBN	amod
claim	NNS	nsubjpass
be	VBP	auxpass
anticipate	VBN	ccomp
by	IN	agent
WO	NNP	pobj
97/49384	CD	nummod
,	,	punct
know	VBN	acl
as	IN	prep
the	DT	det
McGinity	NNP	compound
reference	NN	pobj
,	,	punct
which	WDT	nsubj
later	RB	advmod
become	VBD	relcl
U.S.	NNP	compound
patent	NN	compound
No.	SYM	compound
6,488,963	CD	attr
.	.	punct
District	NNP	compound
Court	NNP	compound
Decision	NNP	dobj
,	,	punct
994	CD	nummod
f.supp.2d	NN	appos
at	IN	prep
421	CD	pobj
-	SYM	punct
26	CD	prep
.	.	punct
the	DT	det
McGinity	NNP	compound
reference	NN	nsubj
disclose	VBZ	ccomp
the	DT	det
use	NN	dobj
of	IN	prep
hot	JJ	amod
-	HYPH	punct
melt	NN	compound
extrusion	NN	pobj
of	IN	prep
high	JJ	amod
molecular	JJ	amod
weight	NN	pobj
peo	NN	appos
to	TO	aux
create	VB	acl
a	DT	det
control	VBN	amod
-	HYPH	punct
release	NN	compound
dosage	NN	compound
form	NN	dobj
for	IN	prep
pharmaceutical	NNS	pobj
.	.	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	ccomp
that	IN	mark
McGinity	NNP	nsubj
disclose	VBD	ccomp
opioid	JJ	amod
formulation	NNS	dobj
and	CC	cc
that	IN	mark
-PRON-	PRP	nsubj
inherently	RB	advmod
disclose	VBD	conj
tablet	NNS	dobj
with	IN	prep
a	DT	det
break	VBG	amod
strength	NN	pobj
in	IN	prep
excess	NN	pobj
of	IN	prep
500	CD	nummod
n	NN	pobj
,	,	punct
as	IN	mark
require	VBN	advcl
by	IN	agent
the	DT	det
assert	VBN	amod
claim	NNS	pobj
.	.	punct
alternatively	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
conclude	VBD	ccomp
that	IN	mark
even	RB	advmod
if	IN	mark
the	DT	det
McGinity	NNP	compound
reference	NN	nsubj
do	VBD	aux
not	RB	neg
anticipate	VB	advcl
the	DT	det
��383	DT	compound
patent	NN	dobj
,	,	punct
"	''	punct
a	DT	det
person	NN	nsubj
of	IN	prep
ordinary	JJ	amod
skill	NN	pobj
in	IN	prep
the	DT	det
art	NN	pobj
would	MD	aux
have	VB	aux
have	VBN	ccomp
sufficient	JJ	amod
knowledge	NN	dobj
and	CC	cc
motivation	NN	conj
to	TO	aux
make	VB	acl
the	DT	det
invention	NN	nsubj
claim	VBN	ccomp
by	IN	agent
the	DT	det
��383	DT	compound
patent	NN	pobj
"	''	punct
.	.	punct
Idaho	NNS	cc
at	IN	prep
426	CD	pobj
.	.	punct

 	_SP	
On	IN	prep
appeal	NN	pobj
,	,	punct
Grunenthal	NNP	nsubj
contend	VBZ	ccomp
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
clearly	RB	advmod
err	VBD	ccomp
in	IN	prep
find	VBG	pcomp
that	IN	mark
McGinity	NNP	nsubj
disclose	VBZ	ccomp
all	DT	dobj
of	IN	prep
the	DT	det
limitation	NNS	pobj
of	IN	prep
the	DT	det
assert	VBN	amod
claim	NNS	pobj
and	CC	cc
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
impermissibly	RB	advmod
combine	VBN	amod
discrete	JJ	amod
disclosure	NNS	appos
in	IN	prep
McGinity	NNP	pobj
to	TO	aux
arrive	VB	conj
at	IN	prep
-PRON-	PRP$	poss
anticipation	NN	compound
determination	NN	pobj
.	.	punct
Grunenthal	NNP	nsubj
also	RB	advmod
assert	VBZ	ccomp
a	DT	det
number	NN	dobj
of	IN	prep
ground	NNS	pobj
of	IN	prep
error	NN	pobj
in	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
obviousness	JJ	amod
determination	NN	pobj
.	.	punct

 	_SP	
a.	NN	compound
McGinity	NNP	poss
's	POS	case
disclosure	NN	nmod
of	IN	prep
Opioid	NNP	compound
Formulations	NNPS	pobj
and	CC	cc
Breaking	NNP	compound
Strength	NNP	conj

 	_SP	
McGinity	NNP	nsubj
disclose	VBZ	ccomp
a	DT	det
variety	NN	dobj
of	IN	prep
therapeutic	JJ	amod
compound	NNS	pobj
to	TO	aux
be	VB	auxpass
use	VBN	relcl
in	IN	prep
-PRON-	PRP$	poss
formulation	NNS	pobj
,	,	punct
include	VBG	prep
"	``	punct
analgesic	NNS	pobj
such	JJ	amod
as	IN	prep
aspirin	NN	pobj
,	,	punct
acetaminophen	NN	conj
,	,	punct
d	NN	det
iflunisal	NN	pobj
and	CC	cc
the	DT	det
like	JJ	conj
"	''	punct
.	.	punct
J.A.	NNP	npadvmod
135074	CD	nummod
.	.	punct
Grunenthal	NNP	nsubj
argue	VBZ	ccomp
that	IN	mark
,	,	punct
because	IN	mark
the	DT	det
only	JJ	advmod
specifically	RB	advmod
mention	VBN	amod
drug	NNS	nsubj
be	VBP	advcl
non	JJ	subtok
-	NNS	subtok
opioid	NNS	attr
,	,	punct
McGinity	NNP	nsubj
do	VBZ	aux
not	RB	neg
describe	VB	ccomp
formulation	NNS	dobj
that	WDT	nsubj
contain	VBP	relcl
opioid	NNS	dobj
such	JJ	amod
as	IN	prep
oxycodone	NN	pobj
.	.	punct
-PRON-	PRP	nsubj
invoke	VBZ	ccomp
the	DT	det
canon	NN	dobj
of	IN	prep
construction	NN	compound
ejusdem	NN	compound
generi	NNS	pobj
-	:	punct
which	WDT	nsubj
provide	VBZ	relcl
that	IN	mark
general	JJ	amod
term	NNS	nsubjpass
be	VBP	auxpass
construe	VBN	ccomp
as	IN	prep
refer	VBG	pcomp
to	IN	prep
thing	NNS	pobj
of	IN	prep
the	DT	det
same	JJ	amod
kind	NN	pobj
as	IN	prep
those	DT	pobj
specifically	RB	advmod
mention	VBN	acl
-	HYPH	punct
to	TO	aux
argue	VB	advcl
that	IN	mark
the	DT	det
term	NNS	nsubjpass
"	''	punct
such	JJ	amod
as	IN	prep
"	``	punct
and	CC	cc
"	''	punct
and	CC	cc
the	DT	det
like	JJ	conj
"	''	punct
should	MD	aux
be	VB	auxpass
understand	VBN	ccomp
as	IN	prep
also	RB	advmod
refer	VBG	pcomp
to	IN	prep
other	JJ	amod
non	JJ	subtok
-	NNS	subtok
opioid	NNS	pobj
.	.	punct
but	CC	cc
,	,	punct
as	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	advcl
,	,	punct
the	DT	det
McGinity	NNP	compound
reference	NN	nsubjpass
can	MD	aux
not	RB	neg
be	VB	auxpass
read	VBN	ccomp
so	RB	advmod
narrowly	RB	advmod
.	.	punct
the	DT	det
McGinity	NNP	compound
reference	NN	nsubj
explicitly	RB	advmod
note	VBZ	ccomp
the	DT	det
use	NN	dobj
of	IN	prep
-PRON-	PRP$	poss
process	NN	pobj
with	IN	prep
analgesic	NNS	pobj
to	TO	aux
treat	VB	acl
pain	NN	dobj
,	,	punct
and	CC	cc
the	DT	det
word	NNS	conj
"	''	punct
such	JJ	amod
as	IN	prep
"	``	punct
and	CC	cc
the	DT	det
residual	JJ	amod
clause	NN	conj
"	''	punct
and	CC	cc
the	DT	det
like	JJ	intj
"	``	punct
demonstrate	VB	conj
that	IN	mark
the	DT	det
application	NN	nsubj
disclose	VBZ	ccomp
a	DT	det
broad	JJR	amod
group	NN	dobj
of	IN	prep
analgesic	NNS	pobj
than	IN	prep
just	RB	advmod
those	DT	pobj
list	VBN	acl
.	.	punct
moreover	RB	advmod
,	,	punct
the	DT	det
record	NN	nsubj
show	VBD	ccomp
that	IN	mark
opioid	NNS	nsubj
be	VBP	ccomp
a	DT	det
major	JJ	amod
class	NN	attr
of	IN	prep
analgesic	NNS	pobj
and	CC	cc
that	DT	det
oxycodone	NN	nsubj
be	VBD	conj
one	CD	attr
of	IN	prep
the	DT	det
most	RBS	advmod
widely	RB	advmod
prescribe	VBN	amod
analgesic	NNS	pobj
at	IN	prep
the	DT	det
time	NN	pobj
.	.	punct
the	DT	det
district	NN	compound
court	NN	nsubj
also	RB	advmod
note	VBD	ccomp
that	IN	mark
the	DT	det
McGinity	NNP	compound
reference	NN	nsubjpass
be	VBZ	auxpass
direct	VBN	ccomp
to	IN	prep
sustain	VBN	amod
-	HYPH	punct
release	NN	compound
dosage	NN	compound
form	NNS	pobj
and	CC	cc
credit	VBD	conj
expert	NN	amod
testimony	NN	dobj
that	WDT	mark
the	DT	det
only	JJ	amod
analgesic	NNS	nsubj
on	IN	prep
the	DT	det
market	NN	pobj
in	IN	prep
a	DT	det
sustain	VBN	amod
-	HYPH	punct
release	NN	compound
form	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
be	VBD	advcl
opioids.4	VBG	attr
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
assessment	NN	nsubj
be	VBZ	conj
persuasive	JJ	acomp
and	CC	cc
not	RB	neg
clearly	RB	advmod
erroneous.5	CD	conj

 	_SP	
Grunenthal	NNP	nsubj
next	RB	advmod
argue	VBZ	ccomp
that	IN	mark
McGinity	NNP	nsubj
do	VBZ	aux
not	RB	neg
inherently	RB	advmod
disclose	VB	ccomp
the	DT	det
limitation	NN	dobj
that	IN	mark
the	DT	det
dosage	NN	compound
form	NNS	nsubj
have	VBP	acl
a	DT	det
breaking	JJ	amod
strength	NN	dobj
of	IN	prep
at	RB	advmod
least	JJS	advmod
500	CD	nummod
n.	NN	pobj
accord	VBG	prep
to	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct

 	_SP	
the	DT	det
pivotal	JJ	amod
evidence	NN	nsubj
[	-LRB-	punct
with	IN	prep
respect	NN	pobj
to	IN	prep
the	DT	det
break	VBG	amod
strength	NN	compound
limitation	NN	pobj
]	-RRB-	punct
be	VBZ	ccomp
a	DT	det
series	NN	attr
of	IN	prep
break	VBG	pcomp
strength	NN	compound
test	NNS	dobj
that	WDT	mark
Dr.	NNP	compound
Fernando	NNP	compound
Muzzio	NNP	nsubj
perform	VBD	relcl
in	IN	prep
preparation	NN	pobj
for	IN	prep
this	DT	det
litigation	NN	pobj
.	.	punct
Muzzio	NNP	nsubj
thermoforme	VBD	ccomp
thousand	NNS	dobj
of	IN	prep
tablet	NNS	pobj
accord	VBG	prep
to	IN	prep
the	DT	det
McGinity	NNP	compound
Application	NNP	compound
disclosure	NNS	pobj
.	.	punct
-PRON-	PRP	nsubj
use	VBD	ccomp
a	DT	det
variety	NN	dobj
of	IN	prep
chemical	NN	compound
composition	NNS	pobj
,	,	punct
extruder	NN	compound
temperature	NNS	conj
,	,	punct
screw	NN	compound
speed	NNS	conj
,	,	punct
and	CC	cc
die	VBP	compound
diameter	NNS	conj
.	.	punct
-PRON-	PRP	nsubj
test	VBD	ccomp
a	DT	det
vast	JJ	amod
number	NN	dobj
of	IN	prep
the	DT	det
result	VBG	amod
tablet	NNS	pobj
,	,	punct
and	CC	cc
without	IN	prep
exception	NN	pobj
-PRON-	PRP	nsubj
withstand	VBD	advcl
force	NNS	dobj
great	JJR	amod
than	IN	prep
500n.	CD	pobj
In	IN	prep
fact	NN	pobj
,	,	punct
Muzzio	NNP	nsubj
often	RB	advmod
exert	VBD	conj
force	NNS	dobj
in	IN	prep
the	DT	det
thousand	NNS	pobj
of	IN	prep
Newtons	NNPS	pobj
and	CC	cc
never	RB	neg
have	VBD	conj
a	DT	det
tablet	NN	compound
break	NN	dobj
.	.	punct

 	_SP	
District	NNP	compound
Court	NNP	compound
Decision	NNP	dep
,	,	punct
994	CD	nummod
f.supp.2d	NN	appos
at	IN	prep
423	CD	pobj
.	.	punct
the	DT	det
district	NN	compound
court	NN	nsubj
credit	VBD	ccomp
Dr.	NNP	compound
Muzzio	NNP	poss
's	POS	case
testing	NN	dobj
and	CC	cc
note	VBD	conj
that	IN	mark
,	,	punct
"	``	punct
in	IN	prep
contrast	NN	pobj
with	IN	prep
[	-LRB-	punct
Dr.	NNP	compound
Muzzio	NNP	poss
's	POS	case
]	-RRB-	punct
persuasive	JJ	amod
experimental	JJ	amod
evidence	NN	pobj
,	,	punct
plaintiff	NNS	nsubj
have	VBP	aux
not	RB	neg
put	VBN	ccomp
forward	RB	prt
any	DT	det
evidence	NN	dobj
that	IN	mark
any	DT	det
tablet	NN	nsubj
produce	VBD	acl
accord	VBG	prep
to	IN	prep
the	DT	det
McGinity	NNP	compound
Application	NNP	pobj
can	MD	aux
ever	RB	advmod
break	VB	relcl
when	WRB	advmod
a	DT	det
force	NN	nsubjpass
of	IN	prep
500n	CD	pobj
be	VBZ	auxpass
apply	VBN	advcl
to	IN	prep
the	DT	det
tablet	NN	pobj
"	''	punct
.	.	punct
Idaho	NNP	advcl
the	DT	det
district	NN	compound
court	NN	nsubj
thus	RB	advmod
conclude	VBD	conj
that	IN	mark
the	DT	det
McGinity	NNP	compound
reference	NN	nsubj
"	''	punct
inherently	RB	advmod
disclose	VBZ	ccomp
a	DT	det
break	VBG	compound
strength	NN	dobj
great	JJR	amod
than	IN	prep
500n	CD	pobj
,	,	punct
because	IN	mark
the	DT	det
experimental	JJ	amod
result	NNS	nsubj
indicate	VBP	advcl
unanimously	RB	advmod
,	,	punct
reliably	RB	advmod
,	,	punct
clearly	RB	advmod
,	,	punct
and	CC	cc
convincingly	RB	advmod
that	IN	mark
any	DT	det
tablet	NN	nsubj
make	VBN	acl
accord	VBG	prep
to	IN	prep
the	DT	det
McGinity	NNP	compound
Application	NNP	pobj
would	MD	aux
exhibit	VB	conj
this	DT	det
characteristic	NN	dobj
"	''	punct
.	.	punct
Idaho	NNS	cc
at	IN	prep
424	CD	pobj
.	.	punct

 	_SP	
Grunenthal	NNP	nsubj
assert	VBZ	ccomp
a	DT	det
number	NN	dobj
of	IN	prep
ground	NNS	pobj
of	IN	prep
error	NN	pobj
,	,	punct
many	JJ	nsubj
of	IN	prep
which	WDT	pobj
focus	VBP	relcl
on	IN	prep
the	DT	det
adequacy	NN	pobj
and	CC	cc
reliability	NN	conj
of	IN	prep
Dr.	NNP	compound
Muzzio	NNP	poss
's	POS	case
testing	NN	pobj
.	.	punct
For	IN	prep
example	NN	pobj
,	,	punct
Grunenthal	NNP	nsubj
argue	VBZ	ccomp
that	IN	mark
Dr.	NNP	compound
Muzzio	NNP	nsubj
do	VBD	aux
not	RB	neg
provide	VB	ccomp
api	NN	compound
release	NN	compound
datum	NNS	dobj
,	,	punct
photograph	NNS	dobj
after	IN	prep
break	VBG	pcomp
strength	NN	compound
testing	NN	dobj
,	,	punct
or	CC	cc
laboratory	NN	compound
notebook	NNS	conj
for	IN	prep
-PRON-	PRP$	poss
reproduction	NNS	pobj
of	IN	prep
the	DT	det
McGinity	NNP	compound
disclosure	NNS	pobj
.	.	punct
but	CC	cc
the	DT	det
district	NN	compound
court	NN	nsubj
reject	VBD	conj
that	DT	det
argument	NN	dobj
,	,	punct
find	VBG	advcl
that	IN	mark
"	``	punct
Muzzio	NNP	nsubj
have	VBZ	aux
supplement	VBN	ccomp
-PRON-	PRP$	poss
own	JJ	amod
credibility	NN	dobj
with	IN	prep
abundant	JJ	amod
documentary	JJ	compound
support	NN	pobj
in	IN	prep
the	DT	det
form	NN	pobj
of	IN	prep
raw	JJ	amod
datum	NNS	pobj
,	,	punct
photograph	NNS	conj
,	,	punct
and	CC	cc
force	NN	compound
curve	NNS	conj
"	''	punct
and	CC	cc
conclude	VBD	conj
that	IN	mark
Grunenthal	NNP	poss
's	POS	case
attack	NNS	nsubj
"	''	punct
do	VBP	aux
not	RB	neg
seriously	RB	advmod
lessen	VB	ccomp
the	DT	det
weight	NN	dobj
the	DT	det
Court	NNP	nsubj
assign	VBZ	relcl
to	IN	prep
Muzzio	NNP	poss
's	POS	case
vast	JJ	amod
empirical	JJ	amod
result	NNS	pobj
and	CC	cc
credible	JJ	amod
opinion	NN	conj
on	IN	prep
the	DT	det
inherency	NN	pobj
of	IN	prep
a	DT	det
500n	CD	nummod
breaking	NN	compound
strength	NN	pobj
"	''	punct
.	.	punct
Idaho	NNP	advcl
similarly	RB	advmod
,	,	punct
Grunenthal	NNP	nsubj
say	VBZ	ROOT
that	IN	mark
Dr.	NNP	compound
Muzzio	NNP	nsubj
do	VBD	aux
not	RB	neg
perform	VB	ccomp
a	DT	det
torque	NN	compound
test	NN	dobj
on	IN	prep
-PRON-	PRP$	poss
reproduction	NNS	pobj
,	,	punct
which	WDT	nsubj
would	MD	aux
have	VB	aux
show	VBN	relcl
if	IN	mark
the	DT	det
extrusion	NN	nsubjpass
be	VBD	aux
be	VBG	auxpass
accurately	RB	advmod
repeat	VBN	ccomp
.	.	punct
again	RB	advmod
,	,	punct
however	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
find	VBD	advcl
that	DT	det
argument	NN	ccomp
unpersuasive	JJ	amod
,	,	punct
conclude	VBG	advcl
that	IN	mark
"	``	punct
because	IN	mark
torque	NN	nsubj
be	VBZ	ccomp
not	RB	neg
an	DT	det
input	NN	attr
or	CC	cc
setting	NN	conj
in	IN	prep
the	DT	det
extrusion	NN	compound
process	NN	pobj
,	,	punct
the	DT	det
lack	NN	nsubj
of	IN	prep
torque	NN	compound
datum	NNS	pobj
do	VBZ	aux
not	RB	neg
affect	VB	conj
the	DT	det
reliability	NN	dobj
of	IN	prep
Muzzio	NNP	poss
's	POS	case
process	NN	pobj
as	IN	prep
a	DT	det
replication	NN	pobj
of	IN	prep
the	DT	det
McGinity	NNP	compound
Application	NNP	poss
's	POS	case
process	NN	pobj
"	''	punct
.	.	punct
Idaho	NNP	meta
the	DT	det
district	NN	compound
court	NN	nsubj
credit	VBD	ccomp
Dr.	NNP	compound
Muzzio	NNP	dobj
with	IN	prep
have	VBG	aux
"	``	punct
recreate	VBN	pcomp
the	DT	det
McGinity	NNP	compound
Application	NNP	poss
's	POS	case
process	NN	dobj
fairly	RB	advmod
,	,	punct
accurately	RB	advmod
,	,	punct
and	CC	cc
with	IN	conj
no	DT	det
material	NN	amod
variation	NN	pobj
,	,	punct
"	''	punct
and	CC	cc
Grunenthal	NNP	nsubj
have	VBZ	aux
show	VBN	conj
no	DT	det
clear	JJ	amod
error	NN	dobj
in	IN	prep
that	DT	det
finding	NN	pobj
.	.	punct

 	_SP	
Grunenthal	NNP	nsubj
also	RB	advmod
point	VBZ	ccomp
to	IN	prep
specific	JJ	amod
disclosure	NNS	pobj
in	IN	prep
McGinity	NNP	pobj
which	WDT	nsubj
-PRON-	PRP	nsubj
argue	VBZ	relcl
show	VBP	ccomp
that	IN	mark
the	DT	det
McGinity	NNP	compound
formulation	NNS	nsubj
do	VBP	aux
not	RB	neg
necessarily	RB	advmod
have	VB	ccomp
the	DT	det
require	VBN	amod
breaking	NN	compound
strength	NN	dobj
.	.	punct
first	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
note	VBZ	advcl
that	IN	mark
McGinity	NNP	nsubj
disclose	VBZ	ccomp
tablet	NNS	dobj
that	WDT	nsubjpass
can	MD	aux
be	VB	auxpass
score	VBN	relcl
-	HYPH	punct
make	VBG	advcl
-PRON-	PRP	nsubj
easy	JJ	ccomp
to	TO	aux
break	VB	advcl
in	IN	prep
half	NN	amod
-	HYPH	punct
or	CC	cc
ground	NN	dobj
,	,	punct
which	WDT	nsubj
-PRON-	PRP	nsubj
contend	VBZ	relcl
be	VBZ	ccomp
the	DT	det
antithesis	NN	attr
of	IN	prep
high	JJ	amod
breaking	NN	amod
strength	NN	compound
tablet	NNS	pobj
.	.	punct
next	RB	advmod
,	,	punct
Grunenthal	NNP	nsubj
argue	VBZ	ccomp
that	IN	mark
McGinity	NNP	nsubj
contemplate	VBZ	ccomp
the	DT	det
use	NN	dobj
of	IN	prep
heat	NN	pobj
or	CC	cc
pressure	NN	conj
to	TO	aux
create	VB	acl
the	DT	det
disclose	VBN	amod
tablet	NNS	dobj
,	,	punct
but	CC	cc
note	VBZ	nsubjpass
that	IN	nsubj
tablet	NNS	ccomp
with	IN	prep
500	CD	nummod
n	NN	compound
break	VBG	amod
strength	NN	pobj
can	MD	aux
only	RB	advmod
be	VB	auxpass
form	VBN	conj
use	VBG	advcl
both	DT	det
heat	NN	dobj
and	CC	cc
pressure	NN	conj
.	.	punct
neither	DT	nsubj
of	IN	prep
those	DT	det
disclosure	NNS	pobj
,	,	punct
however	RB	advmod
,	,	punct
change	VBZ	ccomp
the	DT	det
fact	NN	dobj
that	IN	mark
every	DT	det
tablet	NN	nsubj
make	VBN	acl
accord	VBG	prep
to	IN	prep
McGinity	NNP	poss
's	POS	case
disclosure	NNS	pobj
and	CC	cc
test	VBN	conj
by	IN	agent
Dr.	NNP	compound
Muzzio	NNP	pobj
have	VBD	advcl
a	DT	det
breaking	JJ	amod
strength	NN	dobj
of	IN	prep
over	IN	quantmod
500	CD	nummod
n.	NN	pobj
and	CC	cc
,	,	punct
again	RB	advmod
,	,	punct
Grunenthal	NNP	nsubj
have	VBZ	aux
not	RB	neg
show	VBN	conj
clear	JJ	amod
error	NN	dobj
in	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
crediting	NN	pobj
of	IN	prep
Dr.	NNP	compound
Muzzio	NNP	poss
's	POS	case
testing	NN	compound
result	NNS	pobj
,	,	punct
nor	CC	cc
have	VBZ	aux
-PRON-	PRP	nsubj
provide	VBN	conj
any	DT	det
independent	JJ	amod
testing	NN	dobj
to	TO	aux
rebut	VB	advcl
Dr.	NNP	compound
Muzzio	NNP	poss
's	POS	case
findings.6	CD	punct

 	_SP	
Grunenthal	NNP	poss
's	POS	case
last	JJ	amod
two	CD	nummod
argument	NNS	nsubj
relate	VBP	ccomp
to	IN	prep
test	VBG	pobj
that	IN	mark
Dr.	NNP	compound
Muzzio	NNP	nsubj
do	VBD	aux
not	RB	neg
perform	VB	relcl
.	.	punct
Grunenthal	NNP	nsubj
note	VBZ	ccomp
that	IN	mark
Dr.	NNP	compound
Muzzio	NNP	nsubj
only	RB	advmod
test	VBD	ccomp
formulation	NNS	dobj
with	IN	prep
the	DT	det
active	JJ	amod
ingredient	NN	pobj
disclose	VBN	acl
in	IN	prep
McGinity	NNP	pobj
,	,	punct
chlorpheniramine	NN	amod
maleate	NN	appos
(	-LRB-	punct
"	``	punct
CPM	NNP	appos
"	''	punct
)	-RRB-	punct
,	,	punct
which	WDT	nsubj
be	VBZ	relcl
an	DT	det
antihistamine	NN	attr
,	,	punct
not	RB	neg
an	DT	det
opioid	NN	appos
.	.	punct
thus	RB	advmod
,	,	punct
Grunenthal	NNP	nsubj
say	VBZ	ccomp
that	IN	mark
Dr.	NNP	compound
Muzzio	NNP	poss
's	POS	case
test	NNS	nsubj
only	RB	advmod
prove	VBD	ccomp
that	IN	mark
CPM	NNP	compound
formulation	NNS	nsubj
would	MD	aux
have	VB	ccomp
a	DT	det
breaking	JJ	amod
strength	NN	dobj
of	IN	prep
500	CD	nummod
n	NN	pobj
or	CC	cc
more	JJR	conj
,	,	punct
not	RB	neg
that	IN	nsubj
opioid	NN	csubj
formulation	NNS	dobj
,	,	punct
as	IN	mark
claim	VBN	advcl
in	IN	prep
the	DT	det
��383	DT	compound
patent	NN	pobj
,	,	punct
would	MD	aux
have	VB	advcl
such	PDT	predet
a	DT	det
breaking	JJ	amod
strength	NN	dobj
.	.	punct
but	CC	cc
,	,	punct
Dr.	NNP	compound
Muzzio	NNP	nsubj
testify	VBD	ccomp
that	IN	mark
any	DT	det
tablet	NN	nsubj
make	VBN	acl
use	VBG	xcomp
at	RB	advmod
least	RBS	advmod
fifty	CD	nummod
weight	NN	compound
percent	NN	compound
peo	NN	dobj
and	CC	cc
heat	VBD	conj
above	IN	prep
the	DT	det
melting	NN	compound
point	NN	pobj
of	IN	prep
PEO	NNP	pobj
would	MD	aux
have	VB	ccomp
a	DT	det
breaking	JJ	amod
strength	NN	dobj
above	IN	prep
500	CD	nummod
n	NN	pobj
,	,	punct
regardless	RB	advmod
of	IN	prep
the	DT	det
active	JJ	amod
ingredient	NN	pobj
use	VBN	acl
.	.	punct
J.A.	NNP	npadvmod
3462	CD	nummod
.	.	punct
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
clearly	RB	advmod
err	VB	advcl
in	IN	prep
credit	VBG	pcomp
that	DT	det
testimony	NN	dobj
.	.	punct

 	_SP	
Next	NNP	advmod
,	,	punct
Grunenthal	NNP	nsubj
argue	VBZ	ccomp
that	IN	mark
Dr.	NNP	compound
Muzzio	NNP	nsubj
do	VBD	aux
not	RB	neg
perform	VB	ccomp
any	DT	det
testing	NN	dobj
to	TO	aux
confirm	VB	xcomp
that	IN	mark
the	DT	det
tablet	NNS	nsubj
-PRON-	PRP	nsubj
make	VBD	relcl
accord	VBG	prep
to	IN	prep
the	DT	det
McGinity	NNP	compound
disclosure	NNS	pobj
be	VBD	ccomp
control	VBN	amod
-	HYPH	punct
release	NN	compound
formulation	NNS	attr
.	.	punct
Grunenthal	NNP	nsubj
contend	VBZ	ccomp
that	IN	mark
without	IN	prep
this	DT	det
testing	NN	pobj
,	,	punct
"	''	punct
there	EX	expl
be	VBZ	ccomp
no	DT	det
clear	JJ	amod
proof	NN	attr
that	IN	mark
Teva	NNP	nsubj
actually	RB	advmod
carry	VBD	acl
out	RP	prt
the	DT	det
same	JJ	amod
process	NN	dobj
-	:	punct
and	CC	cc
make	VBD	conj
the	DT	det
same	JJ	amod
tablet	NNS	dobj
-	,	punct
disclose	VBN	acl
in	IN	prep
McGinity	NNP	pobj
"	''	punct
.	.	punct
Grunenthal	NNP	compound
Br	NNP	subtok
.	.	punct
38	CD	nummod
.	.	punct
that	DT	nsubj
be	VBZ	ccomp
incorrect	JJ	acomp
.	.	punct
As	IN	prep
state	VBN	pobj
above	RB	pobj
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
credit	VBD	advcl
Dr.	NNP	compound
Muzzio	NNP	dobj
with	IN	prep
recreate	VBG	pcomp
the	DT	det
McGinity	NNP	compound
process	NN	dobj
"	''	punct
fairly	RB	advmod
,	,	punct
accurately	RB	advmod
,	,	punct
and	CC	cc
with	IN	conj
no	DT	det
material	NN	compound
variation	NN	pobj
"	''	punct
.	.	punct
District	NNP	compound
Court	NNP	compound
Decision	NNP	cc
,	,	punct
994	CD	nummod
f.supp.2d	NN	npadvmod
at	IN	prep
424	CD	pobj
.	.	punct
Grunenthal	NNP	nsubj
have	VBZ	aux
not	RB	neg
show	VBN	ccomp
clear	JJ	amod
error	NN	dobj
in	IN	prep
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
finding	NN	pobj
and	CC	cc
can	MD	aux
not	RB	neg
do	VB	conj
so	RB	advmod
by	IN	prep
claim	VBG	pcomp
that	IN	mark
Dr.	NNP	compound
Muzzio	NNP	nsubj
do	VBD	aux
not	RB	neg
conduct	VB	ccomp
an	DT	det
additional	JJ	amod
test	NN	dobj
to	TO	aux
confirm	VB	advcl
what	WP	dobj
the	DT	det
district	NN	compound
court	NN	nsubj
already	RB	advmod
find	VBN	ccomp
-	:	punct
that	IN	mark
-PRON-	PRP	nsubj
properly	RB	advmod
replicate	VBD	ccomp
the	DT	det
McGinity	NNP	compound
process	NN	dobj
.	.	punct
Grunenthal	NNP	nsubj
also	RB	advmod
say	VBZ	ccomp
that	IN	mark
,	,	punct
without	IN	prep
test	VBG	pcomp
the	DT	det
control	VBN	amod
-	HYPH	punct
release	NN	compound
property	NNS	dobj
of	IN	prep
the	DT	det
tablet	NNS	pobj
,	,	punct
Teva	NNP	nsubj
can	MD	aux
not	RB	neg
prove	VB	ccomp
that	IN	mark
the	DT	det
limitation	NN	nsubjpass
require	VBG	acl
"	``	punct
a	DT	det
control	VBN	amod
release	NN	compound
matrix	NN	dobj
of	IN	prep
[	-LRB-	punct
the	DT	det
PEO	NNP	pobj
]	-RRB-	punct
"	''	punct
be	VBZ	auxpass
disclose	VBN	ccomp
by	IN	agent
McGinity	NNP	pobj
.	.	punct
that	DT	nsubj
be	VBZ	ccomp
also	RB	advmod
incorrect	JJ	acomp
.	.	punct
Teva	NNP	nsubj
do	VBD	aux
not	RB	neg
need	VB	ccomp
to	TO	aux
conduct	VB	xcomp
any	DT	det
control	VBN	amod
-	HYPH	punct
release	NN	compound
testing	NN	dobj
because	IN	mark
McGinity	NNP	nsubj
clearly	RB	advmod
disclose	VBZ	advcl
peo	NN	compound
formulation	NNS	dobj
with	IN	prep
control	VBN	amod
-	HYPH	punct
release	NN	compound
property	NNS	pobj
.	.	punct
For	IN	prep
example	NN	pobj
,	,	punct
in	IN	pobj
the	DT	det
"	``	punct
Field	NNP	pobj
of	IN	prep
the	DT	det
Invention	NNP	nmod
"	''	punct
section	NN	pobj
,	,	punct
McGinity	NNP	nsubj
say	VBZ	pobj
,	,	punct
"	``	punct
the	DT	det
invention	NN	nsubj
relate	VBZ	ccomp
more	RBR	advmod
specifically	RB	advmod
to	IN	prep
formulation	NNS	pobj
which	WDT	nsubjpass
have	VBP	aux
be	VBN	auxpass
prepare	VBN	relcl
by	IN	agent
hot	JJ	amod
melt	NN	amod
extrusion	NN	pobj
of	IN	prep
mixture	NNS	pobj
contain	VBG	acl
high	JJ	amod
molecular	JJ	amod
weight	NN	compound
peo	NN	dobj
and	CC	cc
a	DT	det
therapeutic	JJ	amod
compound	NN	dobj
for	IN	prep
use	NN	pobj
in	IN	prep
control	VBN	amod
-	HYPH	punct
release	NN	compound
drug	NN	compound
delivery	NN	pobj
"	''	punct
.	.	punct
J.A.	NNP	npadvmod
135067	CD	nummod
.	.	punct
thus	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
clearly	RB	advmod
err	VB	ccomp
in	IN	prep
conclude	VBG	pcomp
that	IN	mark
the	DT	det
control	VBN	amod
-	HYPH	punct
release	NN	compound
limitation	NN	nsubjpass
be	VBD	auxpass
disclose	VBN	ccomp
in	IN	prep
McGinity	NNP	pobj
.	.	punct

 	_SP	
B.	NNP	compound
Combination	NNP	cc
of	IN	prep
McGinity	NNP	compound
Disclosures	NNP	pobj

 	_SP	
Finally	NNP	advmod
,	,	punct
Grunenthal	NNP	nsubj
argue	VBZ	ccomp
that	IN	dobj
the	DT	det
district	NN	compound
court	NN	ccomp
err	VBN	acl
by	IN	prep
use	VBG	pcomp
distinct	JJ	amod
section	NNS	dobj
of	IN	prep
McGinity	NNP	pobj
and	CC	cc
reassemble	VBG	conj
-PRON-	PRP	dobj
into	IN	prep
an	DT	det
embodiment	NN	pobj
to	TO	aux
find	VB	acl
that	IN	mark
all	DT	nsubj
of	IN	prep
the	DT	det
limitation	NNS	pobj
be	VBD	ccomp
present	JJ	acomp
.	.	punct
see	VB	advcl
Application	NNP	dobj
of	IN	prep
Arkley	NNP	pobj
,	,	punct
59	CD	nummod
CCPA	NNP	appos
804	CD	nummod
,	,	punct
455	CD	nummod
f.2d	CD	nummod
586	CD	nummod
,	,	punct
587	CD	appos
(	-LRB-	punct
1972	CD	appos
)	-RRB-	punct
(	-LRB-	punct
note	VBG	advcl
that	IN	mark
an	DT	det
anticipate	VBG	compound
reference	NN	nsubj
"	''	punct
must	MD	aux
clearly	RB	advmod
and	CC	cc
unequivocally	RB	advmod
disclose	VB	ccomp
the	DT	det
claim	VBN	amod
compound	NN	dobj
or	CC	cc
direct	VB	conj
those	DT	dobj
skilled	JJ	amod
in	IN	prep
the	DT	det
art	NN	pobj
to	IN	prep
the	DT	det
compound	NN	pobj
without	IN	prep
any	DT	det
need	NN	pobj
for	IN	prep
pick	VBG	pobj
,	,	punct
choose	VBG	conj
,	,	punct
and	CC	cc
combine	VBG	conj
various	JJ	amod
disclosure	NNS	dobj
not	RB	neg
directly	RB	advmod
relate	VBN	ccomp
to	IN	prep
each	DT	det
other	JJ	pobj
by	IN	agent
the	DT	det
teaching	NNS	pobj
of	IN	prep
the	DT	det
cite	VBN	amod
reference	NN	pobj
"	''	punct
)	-RRB-	punct
.	.	punct
For	IN	prep
example	NN	pobj
,	,	punct
Grunenthal	NNP	nsubj
point	VBZ	advmod
out	RP	prt
that	IN	mark
the	DT	det
court	NN	nsubj
select	VBD	ccomp
only	RB	advmod
"	``	punct
analgesic	NNS	dobj
"	''	punct
from	IN	prep
the	DT	det
long	JJ	amod
list	NN	pobj
of	IN	prep
pharmaceutical	JJ	amod
category	NNS	pobj
that	WDT	nsubjpass
could	MD	aux
be	VB	auxpass
use	VBN	relcl
as	IN	prep
the	DT	det
active	JJ	amod
ingredient	NN	pobj
,	,	punct
and	CC	cc
then	RB	advmod
further	RB	advmod
pick	VBD	conj
oxycodone	NN	dobj
,	,	punct
which	WDT	nsubjpass
be	VBD	auxpass
not	RB	neg
even	RB	advmod
disclose	VBN	relcl
,	,	punct
to	TO	aux
find	VB	advcl
anticipation	NN	dobj
.	.	punct
moreover	RB	advmod
,	,	punct
Grunenthal	NNP	nsubj
note	VBZ	ccomp
that	IN	mark
McGinity	NNP	nsubj
teach	VBZ	ccomp
that	IN	mark
the	DT	det
amount	NN	nsubj
of	IN	prep
PEO	NNP	pobj
will	MD	aux
vary	VB	ccomp
depend	VBG	xcomp
on	IN	prep
various	JJ	amod
factor	NNS	pobj
and	CC	cc
do	VBZ	aux
not	RB	neg
consistently	RB	advmod
disclose	VB	conj
formulation	NNS	dobj
with	IN	prep
at	RB	advmod
least	RBS	advmod
sixty	CD	nummod
weight	NN	compound
percent	NN	compound
peo	NN	pobj
,	,	punct
as	IN	mark
require	VBN	advcl
by	IN	agent
the	DT	det
claim	NNS	pobj
.	.	punct
thus	RB	advmod
,	,	punct
Grunenthal	NNP	nsubj
argue	VBZ	ccomp
that	IN	mark
the	DT	det
court	NN	nsubj
impermissibly	RB	advmod
choose	VBD	ccomp
only	RB	advmod
those	DT	det
example	NNS	dobj
that	WDT	nsubj
include	VBD	relcl
the	DT	det
claim	VBN	amod
amount	NN	dobj
of	IN	prep
PEO	NNP	pobj
to	TO	aux
find	VB	advcl
anticipation	NN	dobj
.	.	punct

 	_SP	
These	DT	det
argument	NNS	nsubj
be	VBP	ccomp
without	IN	prep
merit	NN	pobj
.	.	punct
the	DT	det
disclosure	NNS	nsubj
point	VBD	ccomp
to	IN	prep
by	IN	agent
the	DT	det
district	NN	compound
court	NN	pobj
be	VBP	ccomp
all	DT	advmod
"	``	punct
directly	RB	advmod
related	JJ	acomp
"	''	punct
and	CC	cc
thus	RB	advmod
there	EX	expl
be	VBZ	conj
no	DT	det
impermissible	JJ	amod
picking	NN	attr
and	CC	cc
choosing	NN	conj
.	.	punct
Arkley	NNP	dobj
,	,	punct
455	CD	nummod
f.2d	CD	appos
at	IN	prep
587	CD	pobj
.	.	punct
For	IN	prep
example	NN	pobj
,	,	punct
in	IN	prep
the	DT	det
section	NN	pobj
provide	VBG	acl
a	DT	det
detailed	JJ	amod
description	NN	dobj
of	IN	prep
the	DT	det
preferred	JJ	amod
embodiment	NN	pobj
,	,	punct
McGinity	NNP	nsubj
say	VBZ	ccomp
:	:	punct

 	_SP	
the	DT	det
invention	NN	nsubj
provide	VBZ	ccomp
a	DT	det
hot	JJ	amod
-	HYPH	punct
melt	NN	nmod
extrudable	NN	amod
control	VBN	amod
release	NN	compound
pharmaceutical	NN	compound
formulation	NN	dobj
comprise	VBG	acl
an	DT	det
effective	JJ	amod
amount	NN	dobj
of	IN	prep
a	DT	det
therapeutic	JJ	amod
compound	NN	pobj
,	,	punct
high	JJ	amod
molecular	JJ	amod
weight	NN	conj
[	-LRB-	punct
peo	NN	appos
]	-RRB-	punct
...	NFP	punct
,	,	punct
the	DT	det
[	-LRB-	punct
peo]:therapeutic	JJ	det
compound	NN	compound
ratio	NN	nsubj
be	VBG	ccomp
in	IN	prep
the	DT	det
range	NN	pobj
from	IN	prep
about	IN	quantmod
99.99:0.01	CD	pobj
to	IN	prep
about	IN	advmod
80:20	CD	nummod
%	NN	pobj
wt	NN	nummod
.	.	punct

 	_SP	
J.A.	NNP	npadvmod
135802	CD	nummod
.	.	punct
In	IN	prep
that	DT	det
single	JJ	amod
disclosure	NN	pobj
,	,	punct
McGinity	NNP	nsubj
describe	VBZ	ccomp
the	DT	det
control	VBN	amod
-	HYPH	punct
release	NN	compound
formulation	NN	dobj
and	CC	cc
the	DT	det
use	NN	conj
of	IN	prep
over	IN	quantmod
sixty	CD	nummod
weight	NN	compound
percent	NN	compound
peo	NN	pobj
.	.	punct
-PRON-	PRP	nsubj
do	VBZ	aux
not	RB	neg
specifically	RB	advmod
say	VB	ccomp
what	WP	det
therapeutic	JJ	amod
compound	NN	nsubjpass
be	VBZ	auxpass
use	VBN	ccomp
,	,	punct
but	CC	cc
-PRON-	PRP	nsubj
provide	VBZ	conj
a	DT	det
list	NN	dobj
of	IN	prep
the	DT	det
type	NNS	pobj
of	IN	prep
therapeutic	JJ	amod
compound	NNS	pobj
contemplate	VBN	acl
.	.	punct
that	DT	det
list	NN	nsubjpass
of	IN	prep
compound	NNS	pobj
,	,	punct
although	IN	prep
in	IN	prep
a	DT	det
distinct	JJ	amod
section	NN	pobj
of	IN	prep
the	DT	det
reference	NN	pobj
,	,	punct
be	VBZ	auxpass
directly	RB	advmod
relate	VBN	advcl
to	IN	prep
the	DT	det
disclosure	NN	pobj
reproduce	VBN	acl
above	RB	advmod
.	.	punct
thus	RB	advmod
,	,	punct
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
impermissibly	RB	advmod
combine	VB	ccomp
distinct	JJ	amod
disclosure	NNS	dobj
in	IN	prep
McGinity	NNP	pobj
to	TO	aux
arrive	VB	xcomp
at	IN	prep
the	DT	det
claim	VBN	amod
invention	NN	pobj
.	.	punct

 	_SP	
-PRON-	PRP	nsubj
conclude	VBP	ccomp
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
clearly	RB	advmod
err	VB	ccomp
in	IN	prep
find	VBG	pcomp
that	IN	mark
the	DT	det
McGinity	NNP	compound
reference	NN	nsubj
disclose	VBZ	ccomp
each	DT	amod
and	CC	cc
every	DT	conj
limitation	NN	dobj
in	IN	prep
the	DT	det
asserted	JJ	amod
claim	NNS	pobj
of	IN	prep
the	DT	det
��383	DT	compound
patent	NN	pobj
.	.	punct
-PRON-	PRP	nsubj
thus	RB	advmod
affirm	VBP	ccomp
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
anticipation	NN	compound
determination	NN	dobj
and	CC	cc
do	VBP	aux
not	RB	neg
reach	VB	conj
the	DT	det
question	NN	dobj
of	IN	prep
obviousness	JJ	pobj
.	.	punct

 	_SP	
III	NNP	cc
.	.	punct
Collateral	NNP	compound
Estoppel	NNP	nsubj

  	_SP	
In	IN	prep
addition	NN	pobj
to	IN	prep
appeal	VBG	pcomp
the	DT	det
judgment	NNS	dobj
of	IN	prep
invalidity	NN	pobj
,	,	punct
Purdue	NNP	nsubj
also	RB	advmod
appeal	VBZ	ccomp
the	DT	det
dismissal	NN	dobj
of	IN	prep
the	DT	det
Epic	NNP	pobj
,	,	punct
Mylan	NNP	conj
,	,	punct
and	CC	cc
amneal	JJ	compound
action	NNS	conj
with	IN	prep
respect	NN	pobj
to	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
patent	NNS	pobj
.	.	punct
On	IN	prep
appeal	NN	pobj
from	IN	prep
order	NNS	pobj
of	IN	prep
dismissal	NN	pobj
due	IN	prep
to	IN	pcomp
collateral	JJ	amod
estoppel	NN	pobj
,	,	punct
"	''	punct
-PRON-	PRP$	poss
role	NN	nsubjpass
be	VBZ	auxpass
limit	VBN	advcl
to	IN	prep
review	VBG	pcomp
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
application	NN	dobj
of	IN	prep
collateral	JJ	amod
estoppel	NN	pobj
,	,	punct
not	RB	neg
the	DT	det
correctness	NN	appos
of	IN	prep
the	DT	det
[	-LRB-	punct
underlie	VBG	amod
]	-RRB-	punct
verdict	NN	pobj
[	-LRB-	punct
]	-RRB-	punct
.	.	punct

"	''	punct
Pharmacia	NNP	nsubj
&	CC	cc
Upjohn	NNP	compound
Co.	NNP	conj
v.	CC	prep
Mylan	NNP	nmod
Pharm.	NNP	nmod
,	,	punct
Inc.	NNP	pobj
,	,	punct
170	CD	nummod
f.3d	CD	appos
1373	CD	nummod
,	,	punct
1380	CD	appos
(	-LRB-	punct
Fed	NNP	appos
.	.	punct
Cir.1999	NNP	ccomp
)	-RRB-	punct
.	.	punct
Before	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct
Purdue	NNP	nsubj
concede	VBD	advcl
that	IN	mark
collateral	JJ	amod
estoppel	NN	nsubj
apply	VBN	ccomp
to	IN	prep
the	DT	det
judgment	NN	pobj
of	IN	prep
invalidity	NN	pobj
as	IN	prep
to	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
patent	NNS	pobj
in	IN	prep
the	DT	det
Teva	NNP	compound
case	NN	pobj
,	,	punct
which	WDT	nsubj
preclude	VBD	relcl
-PRON-	PRP	dobj
from	IN	prep
obtain	VBG	pcomp
the	DT	det
relief	NN	dobj
seek	VBN	acl
in	IN	prep
the	DT	det
remain	VBG	amod
action	NNS	pobj
.	.	punct
Purdue	NNP	nsubj
also	RB	advmod
do	VBZ	aux
not	RB	neg
present	VB	ccomp
any	DT	det
persuasive	JJ	amod
argument	NN	dobj
on	IN	prep
appeal	NN	pobj
as	IN	prep
to	IN	prep
why	WRB	advmod
collateral	JJ	amod
estoppel	NN	nsubj
should	MD	aux
not	RB	neg
apply	VB	pcomp
.	.	punct
thus	RB	advmod
,	,	punct
-PRON-	PRP	nsubj
affirm	VBP	ccomp
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
dismissal	NN	dobj
of	IN	prep
the	DT	det
remain	VBG	amod
action	NNS	pobj
as	IN	mark
bar	VBN	advcl
by	IN	agent
collateral	JJ	amod
estoppel	NN	pobj
.	.	punct

 	_SP	
For	IN	prep
the	DT	det
forego	VBG	compound
reason	NNS	pobj
,	,	punct
-PRON-	PRP	nsubj
affirm	VBP	advcl
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
invalidity	NN	compound
determination	NNS	dobj
as	IN	prep
to	IN	prep
the	DT	det
low	JJ	amod
-	HYPH	punct
abuk	JJ	compound
patent	NNS	pobj
and	CC	cc
the	DT	det
��383	DT	compound
patent	NN	conj
and	CC	cc
the	DT	det
district	NN	compound
court	NN	poss
's	POS	case
dismissal	NN	conj
of	IN	prep
the	DT	det
Epic	NNP	pobj
,	,	punct
Mylan	NNP	conj
,	,	punct
and	CC	cc
amneal	JJ	conj
action	NNS	conj
.	.	punct

 	_SP	
all	DT	det
Citations	NNPS	dobj

 	_SP	
811	CD	nummod
f.3d	CD	appos
1345	CD	appos
,	,	punct
117	CD	nummod
U.S.P.Q.2d	NNS	appos
1733	CD	nummod

 	_SP	
Footnotes	NNP	conj

 	_SP	
Honorable	NNP	compound
Leonard	NNP	compound
P.	NNP	compound
Stark	NNP	conj
,	,	punct
Chief	NNP	compound
District	NNP	compound
Judge	NNP	conj
,	,	punct
United	NNP	compound
States	NNP	compound
District	NNP	compound
Court	NNP	conj
for	IN	prep
the	DT	det
District	NNP	pobj
of	IN	prep
Delaware	NNP	pobj
,	,	punct
sit	VBG	acl
by	IN	prep
designation	NN	pobj
.	.	punct

 	_SP	
Before	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
,	,	punct
Purdue	NNP	nsubj
accuse	VBD	advcl
Teva	NNP	dobj
of	IN	prep
infringe	VBG	pcomp
claim	NNS	dobj
3	CD	nummod
and	CC	cc
19	CD	conj
of	IN	prep
the	DT	det
��799	NN	compound
patent	NN	pobj
,	,	punct
claim	VBZ	conj
30	CD	npadvmod
-	SYM	punct
34	CD	prep
and	CC	cc
76	CD	conj
-	SYM	punct
79	CD	prep
of	IN	prep
the	DT	det
��	NN	nmod
800	CD	nummod
patent	NN	pobj
,	,	punct
claim	VBZ	acl
1	CD	conj
,	,	punct
4	CD	npadvmod
,	,	punct
and	CC	cc
5	CD	conj
of	IN	prep
the	DT	det
��072	NN	compound
patent	NN	pobj
,	,	punct
and	CC	cc
claim	VBZ	conj
1	CD	npadvmod
,	,	punct
2	CD	npadvmod
,	,	punct
5	CD	appos
,	,	punct
7	CD	conj
,	,	punct
and	CC	cc
8	CD	conj
of	IN	prep
the	DT	det
��383	DT	compound
patent	NN	pobj
.	.	punct

 	_SP	
all	DT	nsubj
of	IN	prep
the	DT	det
assert	VBN	amod
claim	NNS	pobj
be	VBP	ccomp
product	NN	compound
claim	NNS	attr
.	.	punct
the	DT	det
asserted	JJ	amod
claim	NNS	nsubjpass
of	IN	prep
the	DT	det
��072	NN	compound
patent	NN	pobj
be	VBP	auxpass
direct	VBN	ccomp
to	IN	aux
"	``	punct
an	DT	det
oxycodone	NN	compound
hydrochloride	VBP	advcl
active	JJ	amod
pharmaceutical	NN	amod
ingredient	NN	dobj
"	''	punct
with	IN	prep
low	JJ	amod
ABUK	NNP	compound
level	NNS	pobj
,	,	punct
see	VB	conj
,	,	punct
e.g.	RB	advmod
,	,	punct
��072	CD	compound
patent	NN	compound
col.	NN	appos
34	CD	nummod
will	NN	intj
.	.	punct
57	CD	npadvmod
-	SYM	punct
60	CD	prep
,	,	punct
while	IN	mark
the	DT	det
assert	VBN	amod
claim	NNS	nsubjpass
of	IN	prep
the	DT	det
��799	NN	compound
patent	NN	pobj
be	VBP	auxpass
direct	VBN	advcl
to	IN	prep
an	DT	det
"	``	punct
oral	JJ	amod
dosage	NN	compound
form	NN	pobj
"	''	punct
of	IN	prep
low	JJ	amod
-	HYPH	punct
abuk	NN	compound
oxycodone	NN	compound
hydrochloride	NN	pobj
,	,	punct
see	VB	intj
,	,	punct
e.g.	RB	advmod
,	,	punct
��799	,	compound
patent	NN	compound
col.	NN	parataxis
35	CD	nummod
will	NN	subtok
.	.	punct
8	CD	npadvmod
-	SYM	punct
15	CD	prep
.	.	punct
the	DT	det
asserted	JJ	amod
claim	NNS	nsubj
of	IN	prep
the	DT	det
��	NN	nmod
800	CD	nummod
patent	NN	pobj
be	VBP	ccomp
product	NN	nmod
-	HYPH	punct
by	IN	prep
-	HYPH	punct
process	NN	pobj
claim	NNS	attr
;	:	punct
-PRON-	PRP	nsubjpass
be	VBP	auxpass
direct	VBN	ccomp
to	IN	aux
"	``	punct
oxycodone	NN	compound
salt	NN	pobj
prepare	VBD	xcomp
accord	VBG	prep
to	IN	prep
[	-LRB-	punct
a	DT	det
]	-RRB-	punct
process	NN	pobj
"	''	punct
that	IN	nsubj
yield	VBZ	relcl
low	JJ	amod
ABUK	NNP	compound
level	NNS	dobj
.	.	punct
see	VB	npadvmod
,	,	punct
e.g.	RB	advmod
,	,	punct
��800	DT	aux
patent	NN	compound
col.	NN	dobj
35	CD	nummod
will	NN	intj
.	.	punct
49	CD	npadvmod
-	SYM	punct
50	CD	prep
.	.	punct

 	_SP	
Claim	NNP	nsubj
1	CD	nummod
be	VBZ	punct
the	DT	det
only	JJ	amod
independent	JJ	amod
claim	NN	attr
of	IN	prep
the	DT	det
��383	DT	compound
patent	NN	pobj
and	CC	cc
recite	VBZ	conj
:	:	punct

 	_SP	
a	DT	det
thermoformed	JJ	amod
dosage	NN	compound
form	NN	nsubj
comprising	NN	ccomp
:	:	punct

 	_SP	
i	LS	pobj
)	-RRB-	punct
one	CD	nummod
or	CC	cc
more	RBR	advmod
active	JJ	conj
ingredient	NNS	attr
with	IN	prep
abuse	NN	compound
potential	JJ	pobj
(	-LRB-	punct
a	NN	appos
)	-RRB-	punct
select	VBN	acl
from	IN	prep
the	DT	det
group	NN	pobj
consist	VBG	acl
of	IN	prep
opiate	NNS	pobj
and	CC	cc
opioid	NNS	conj
,	,	punct

 	_SP	
ii	LS	intj
)	-RRB-	punct
optionally	RB	advmod
physiologically	RB	advmod
acceptable	JJ	amod
auxiliary	JJ	amod
substance	NNS	attr
(	-LRB-	punct
B	NNP	appos
)	-RRB-	punct
,	,	punct

 	_SP	
iii	LS	acomp
)	-RRB-	punct
at	RB	advmod
least	RBS	advmod
60	CD	nummod
%	NN	npadvmod
by	IN	prep
weight	NN	pobj
of	IN	prep
polyalkylene	NN	compound
oxide	NN	pobj
(	-LRB-	punct
c	NN	appos
)	-RRB-	punct
have	VBG	acl
a	DT	det
molecular	JJ	amod
weight	NN	dobj
of	IN	prep
1	CD	compound
-	SYM	punct
15	CD	compound
million	CD	pobj
accord	VBG	prep
to	IN	prep
rheological	JJ	amod
measurement	NNS	pobj
,	,	punct
and	CC	cc

 	_SP	
iv	LS	conj
)	-RRB-	punct
optionally	RB	advmod
at	RB	advmod
least	JJS	advmod
one	CD	nummod
wax	NN	appos
(	-LRB-	punct
D	NNP	appos
)	-RRB-	punct
wherein	WRB	advmod
say	VBD	ROOT
dosage	NN	compound
form	NN	nsubj
have	VBZ	ccomp
a	DT	det
breaking	JJ	amod
strength	NN	nsubj
of	IN	prep
at	RB	advmod
least	JJS	advmod
500	CD	nummod
n	NN	pobj
and	CC	cc
wherein	WRB	conj
the	DT	det
active	JJ	amod
ingredient	NN	dobj
with	IN	prep
abuse	NN	compound
potential	JJ	pobj
(	-LRB-	punct
a	NN	appos
)	-RRB-	punct
be	VBZ	ccomp
present	JJ	acomp
in	IN	prep
a	DT	det
control	VBN	amod
release	NN	compound
matrix	NN	pobj
of	IN	prep
component	NN	pobj
(	-LRB-	punct
C	NNP	appos
)	-RRB-	punct
.	.	punct

 	_SP	
Grunenthal	NNP	cc
say	VBZ	ccomp
that	IN	mark
the	DT	det
record	NN	compound
evidence	NN	nsubj
expressly	RB	advmod
contradict	VBZ	ccomp
this	DT	det
testimony	NN	dobj
,	,	punct
as	IN	mark
-PRON-	PRP	nsubj
show	VBZ	advcl
that	IN	mark
there	EX	expl
be	VBD	ccomp
,	,	punct
in	IN	prep
fact	NN	pobj
,	,	punct
three	CD	nummod
analgesic	NNS	attr
on	IN	prep
the	DT	det
market	NN	pobj
in	IN	prep
a	DT	det
sustain	VBN	amod
-	HYPH	punct
release	NN	compound
form	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
and	CC	cc
only	RB	advmod
two	CD	nsubj
of	IN	prep
-PRON-	PRP	pobj
be	VBD	conj
opioid	NNS	attr
.	.	punct
but	CC	cc
Grunenthal	NNP	nsubj
never	RB	neg
make	VBD	conj
that	DT	det
argument	NN	dobj
before	IN	prep
the	DT	det
district	NN	compound
court	NN	pobj
-	:	punct
-PRON-	PRP	nsubj
do	VBD	aux
not	RB	neg
cross	VB	subtok
-	VB	subtok
examine	VB	amod
the	DT	det
expert	NN	pobj
on	IN	prep
this	DT	det
point	NN	pobj
or	CC	cc
otherwise	RB	advmod
take	VBP	conj
issue	NN	dobj
with	IN	prep
the	DT	det
accuracy	NN	pobj
of	IN	prep
the	DT	det
expert	NN	compound
testimony	NN	pobj
.	.	punct
In	IN	prep
any	DT	det
event	NN	pobj
,	,	punct
the	DT	det
fact	NN	nsubj
that	IN	mark
two	CD	nsubj
of	IN	prep
the	DT	det
three	CD	nummod
sustain	VBN	amod
-	HYPH	punct
release	NN	compound
drug	NNS	pobj
on	IN	prep
that	DT	det
market	NN	pobj
at	IN	prep
the	DT	det
time	NN	pobj
be	VBD	acl
opioid	NNS	attr
be	VBZ	ccomp
persuasive	JJ	amod
evidence	NN	attr
that	IN	mark
a	DT	det
skilled	JJ	amod
artisan	NN	nsubj
would	MD	aux
understand	VB	acl
McGinity	NNP	dobj
as	IN	prep
describe	VBG	pcomp
formulation	NNS	dobj
that	WDT	nsubj
use	VBP	relcl
opioid	NNS	dobj
.	.	punct

 	_SP	
Grunenthal	NNP	nsubj
also	RB	advmod
contend	VBZ	ccomp
that	IN	mark
McGinity	NNP	nsubj
do	VBZ	aux
not	RB	neg
disclose	VB	ccomp
the	DT	det
limitation	NN	dobj
that	IN	mark
the	DT	det
active	JJ	amod
ingredient	NN	nsubj
have	VBZ	relcl
"	``	punct
abuse	NN	compound
potential	JJ	dobj
"	''	punct
.	.	punct
��383	DT	det
patent	NN	compound
col.	NN	ccomp
.	.	punct
Because	IN	mark
-PRON-	PRP	nsubj
find	VBP	advcl
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
err	VB	ccomp
in	IN	prep
conclude	VBG	pcomp
that	IN	mark
McGinity	NNP	nsubj
disclose	VBZ	ccomp
the	DT	det
use	NN	dobj
of	IN	prep
an	DT	det
opioid	NN	pobj
as	IN	prep
an	DT	det
active	JJ	amod
ingredient	NN	pobj
,	,	punct
and	CC	cc
because	IN	mark
the	DT	det
record	NN	nsubj
clearly	RB	advmod
demonstrate	VBZ	advcl
that	IN	mark
opioid	NNS	nsubj
have	VBP	ccomp
abuse	NN	compound
potential	JJ	dobj
,	,	punct
-PRON-	PRP	nsubj
similarly	RB	advmod
find	VBP	ccomp
that	IN	mark
the	DT	det
district	NN	compound
court	NN	nsubj
do	VBD	aux
not	RB	neg
err	VB	ccomp
in	IN	prep
conclude	VBG	pcomp
that	IN	mark
McGinity	NNP	nsubj
disclose	VBZ	ccomp
formulation	NNS	nsubj
where	WRB	advmod
the	DT	det
active	JJ	amod
ingredient	NN	nsubj
have	VBZ	aux
abuse	NN	ccomp
potential	JJ	dobj
.	.	punct

 	_SP	
moreover	RB	advmod
,	,	punct
Grunenthal	NNP	nsubj
incorrectly	RB	advmod
characterize	VBZ	ccomp
the	DT	det
McGinity	NNP	compound
disclosure	NNS	dobj
.	.	punct
Grunenthal	NNP	nsubj
rely	VBZ	ccomp
on	IN	prep
one	CD	nummod
isolate	VBN	amod
sentence	NN	pobj
to	TO	aux
support	VB	xcomp
-PRON-	PRP$	poss
argument	NN	dobj
that	IN	mark
McGinity	NNP	nsubj
contemplate	VBZ	acl
the	DT	det
use	NN	dobj
of	IN	prep
heat	NN	pobj
or	CC	cc
pressure	NN	conj
in	IN	prep
-PRON-	PRP$	poss
process	NN	pobj
:	:	punct
"	``	punct
a	DT	det
hot	JJ	amod
-	HYPH	punct
melt	NN	amod
extrudable	JJ	amod
polymer	NN	nsubj
be	VBZ	ccomp
one	CD	attr
that	WDT	nsubj
be	VBZ	relcl
...	:	punct
capable	JJ	acomp
of	IN	prep
deformation	NN	pobj
...	:	punct
under	IN	prep
elevated	JJ	amod
heat	NN	pobj
or	CC	cc
pressure	NN	conj
"	''	punct
.	.	punct
J.A.	NNP	npadvmod
135076	CD	nummod
.	.	punct
but	CC	cc
that	DT	det
sentence	NN	nsubj
merely	RB	advmod
define	VBZ	ccomp
the	DT	det
type	NN	dobj
of	IN	prep
polymer	NN	pobj
use	VBN	acl
;	:	punct
-PRON-	PRP	nsubj
do	VBZ	aux
not	RB	neg
say	VB	ccomp
that	IN	mark
the	DT	det
extrusion	NN	compound
process	NN	nsubj
require	VBZ	ccomp
only	JJ	advmod
heat	NN	dobj
or	CC	cc
pressure	NN	conj
and	CC	cc
not	RB	neg
both	DT	conj
.	.	punct
In	IN	prep
fact	NN	pobj
,	,	punct
in	IN	prep
describe	VBG	pcomp
the	DT	det
actual	JJ	amod
hot	JJ	amod
-	HYPH	punct
melt	NN	compound
process	NN	dobj
,	,	punct
McGinity	NNP	nsubj
say	VBZ	ccomp
-PRON-	PRP	nsubjpass
should	MD	aux
be	VB	auxpass
"	``	punct
conduct	VBN	ccomp
at	IN	prep
an	DT	det
elevated	JJ	amod
temperature	NN	pobj
"	''	punct
and	CC	cc
explain	VBZ	conj
that	IN	mark
the	DT	det
pharmaceutical	NN	amod
mixture	NN	nsubjpass
should	MD	aux
be	VB	auxpass
"	``	punct
pass	VBN	ccomp
through	IN	prep
the	DT	det
heated	JJ	amod
area	NN	pobj
of	IN	prep
the	DT	det
extruder	NN	pobj
at	IN	prep
a	DT	det
temperature	NN	pobj
which	WDT	nsubj
will	MD	aux
melt	VB	relcl
or	CC	cc
soften	VB	conj
the	DT	det
peo	NN	dobj
"	''	punct
.	.	punct
J.A.	NNP	npadvmod
135077	CD	nummod
.	.	punct
indeed	RB	advmod
,	,	punct
Grunenthal	NNP	poss
's	POS	case
own	JJ	amod
expert	NN	nsubj
testify	VBD	ccomp
that	IN	mark
hot	JJ	amod
-	HYPH	punct
melt	NN	compound
extrusion	NN	nsubj
require	VBZ	ccomp
achieve	VBG	xcomp
the	DT	det
"	``	punct
melt	NN	amod
flow	NN	nmod
"	''	punct
temperature	NN	dobj
of	IN	prep
ninety	CD	compound
-	HYPH	punct
eight	CD	nummod
degree	NNS	pobj
Celsius	NNP	appos
for	IN	prep
high	JJ	amod
molecular	JJ	amod
weight	NN	compound
peo	NN	pobj
.	.	punct
J.A.	NNP	cc
3845	CD	npadvmod
-	SYM	punct
46	CD	prep
.	.	punct

 	_SP	

